WO2008015975A1 - Method for amplification of dna fragment - Google Patents
Method for amplification of dna fragment Download PDFInfo
- Publication number
- WO2008015975A1 WO2008015975A1 PCT/JP2007/064774 JP2007064774W WO2008015975A1 WO 2008015975 A1 WO2008015975 A1 WO 2008015975A1 JP 2007064774 W JP2007064774 W JP 2007064774W WO 2008015975 A1 WO2008015975 A1 WO 2008015975A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dna fragment
- pcr
- dna
- transposon
- adapter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
- C12Q1/6855—Ligating adaptors
Definitions
- the present invention relates to a method for amplifying a DNA fragment, and more particularly to a method for amplifying a DNA fragment used in a transposon display method for rapidly and objectively associating a trait and a gene associated therewith.
- genomic DNA is not limited to just determining the entire base sequence of genomic DNA. It is also necessary to analyze the effects of each gene described in the above on the traits of plants, that is, the functions of each gene.
- One method of analyzing the function of the gene is the transposon display method described below.
- the transposon is also called a transposable genetic element or a mobile genetic element (mobile genetic element, movable genetic element). It is a DNA fragment that has the property of randomly translocating to other sites, and is known to cause gene disruption by inserting into the translocation target gene.
- transposons that function in rice Tosl7, karma (see Patent Literature 1), mPing (see Patent Literature 2 and Non-Patent Literature 1) have already been reported.
- the transposon display method is a method for examining the function of a gene by using the above-mentioned properties of the transposon, and a gene related to a certain trait is determined based on the gene disruption caused by the transposon and a change in the trait associated therewith. It is a method to identify, specifically (Refer to Patent Document 2).
- genomic DNA is extracted from a plurality of individuals of the same strain whose traits have changed due to transposon transposition, and a DNA fragment containing a part of the transposon is amplified.
- the amplified DNA fragments are electrophoresed to obtain waveform data for each individual, and the differences in the waveform data for each individual, in short, the presence or absence of peaks are analyzed.
- a specific trait is associated with a specific gene by comparing the difference in the presence or absence of the peak of each individual with the difference in the trait.
- amplification of a DNA fragment containing a part of the transposon consists of (l) DNA extraction step, (2) adapter addition step, (3) first PCR step (hereinafter referred to as first PCR step) (4) It can be roughly divided into each step of the second PCR step (hereinafter referred to as the second PCR step). Details of these will be described below with reference to FIG. 8, which is a schematic diagram.
- FIG. 8 (a) schematically shows genomic DNA extracted from an individual. Show.
- T means a transposon
- IR means an inverted repeat.
- the extracted genomic DNA is partially digested with a restriction enzyme, and oligomer DNA (adapter) that can bind to the recognition site by this restriction enzyme is ligated to the partially digested DNA.
- Fig. 8 (b) shows the state before ligation
- Fig. 8 (c) shows the state after ligation.
- the partial digest of genomic DNA is a mixture of partial digest 1 that contains a part of transposon T and partial digest 2 that does not contain transposon T, and the adapter ligates to either of them.
- Ligation products are also a mixture of 3 with and without 4!
- the first PCR step is performed on both sides using two primers: primer 1 specific for a part of the base sequence of transposon T and primer 2 complementary to the adapter.
- a PCR reaction step where a PCR product as shown in Fig. 8 (d) It is a process to obtain.
- primer product 1 and primer 2 are annealed to ligation product 3 to produce PCR product 5.
- primer 1 cannot be annealed to ligation product 4, so primer 2 is annealed at both ends to produce PCR product 6.
- the DNA fragment 4 and the DNA fragment 6 have the same force. For convenience in illustration, different numbers are assigned.
- the second PCR step consists of PCR products 5 and 6 in a saddle shape, a labeled primer 3 specific for a part of transposon T and a primer complementary to the adapter 2 Is a step of performing a PCR reaction using
- the PCR product 5 containing a part of the transposon is annealed with labeled primer 3 and primer 2 to generate labeled PCR product 7.
- primer 3 cannot be annealed to PCR product 6, so primer 2 is annealed at both ends to produce PCR product 8.
- the amplified DNA fragments are labeled PCR product 7 and unlabeled PCR product.
- both ligation products 3 and 4 must have adapters at both ends, and primer 2 that is complementary to this adapter is used in both the first PCR step and the second PCR reaction. Therefore, the ratio of labeled PCR product 7 to unlabeled PCR product 8 in the PCR product is almost the same as the ratio of DNA fragment 1 containing a part of transposon T and DNA fragment 2 not containing this.
- the DNA fragment thus obtained is used for electrophoresis, analysis of waveform data, and correlation between a trait and a gene.
- analysis of waveform data obtained by electrophoresis has been performed manually based on the experience and intuition of the experimenter. Therefore, it took a lot of time and labor, and the analysis results were not objective because there were individual differences.
- the inventors have developed the “Rice Transposon Analysis Support System” through the “Wakayama Prefectural Community Research Project”. Create and use! /, Ru (see Patent Document 3).
- the size marker and the PCR product are mixed and electrophoresed to convert the migration time constituting the waveform data into the size (number of bases) of the amplified product, and the fluorescence intensity of the waveform data. Can be quantified. Therefore, waveform data based on different electrophoresis It is possible to easily and objectively compare the waveform data by correcting the force as applied by the same electrophoresis.
- the transposon display method is a useful method for associating a certain trait with a gene associated therewith, and its usefulness has been further improved by using the above-described system in particular.
- Patent Document 1 Japanese Patent Application No. 2002-369691
- Patent Document 2 U.S. Pat.No. 6,420,117
- Patent Document 3 Japanese Patent Application No. 2005-237438
- Non-Patent Document 1 Nakazaki et al. (Nakazaki, T.), Movement of transposon in the rice genome (Nature;, 421 (2003), p.170-172)
- Non-Patent Document 2 Junya Yoshida, Kuniko Shio, "Simple rice extraction method from rice grain and discrimination of sake rice varieties by RAPD", [online], Chinese Agricultural Experiment Station, 1998 research result information, [May 10, 2006 Search], Internet ⁇ URL: http: ⁇ www.affrc.go.jp/seika/data#cgk/hlO / seibuti cgkgSOCM.html>
- the present invention is a method for amplifying a DNA fragment used in the transposon display method, wherein the waveform data obtained by electrophoresis of the DNA fragment has a waveform pattern that has a strong peak intensity and is difficult to attenuate. It is an object of the present invention to provide a method for amplifying a DNA fragment that can be used for analysis of a longer part and that has little individual difference in experimental results.
- the inventor has examined the reason why the intensity of the peak constituting the waveform data is weak and the attenuation is intense. As a result, the inventor amplified the same amount of unlabeled PCR product 8 as well as labeled PCR product 7 in the first PCR step and second PCR step. This is because primers and nucleic acid monomers (d) that are used at the same time are wasted for amplification of the unlabeled PCR product 8, and the amplification of the labeled PCR product 7 is not performed in proportion to the number of cycles. I thought.
- the inventor solves the above problem by amplifying only the labeled PCR product, that is, by improving the ratio of the labeled PCR product 7 in the PCR product (hereinafter, S / N ratio).
- S / N ratio the ratio of the labeled PCR product 7 in the PCR product
- the method for amplifying a DNA fragment of the present invention comprises (1) a DNA extraction step for extracting genomic DNA from cells of a higher plant, and (2) partial digestion of genomic DNA with a restriction enzyme to obtain a DNA fragment.
- a first PCR step for amplifying a DNA fragment by a one-side PCR method and (4) a DNA fragment amplified by the first PCR step in a saddle shape, and a labeled primer specific for the transposon and the This includes a second PCR step in this order that amplifies the DNA fragment by a two-sided PCR method using primers complementary to the adapter.
- the power of the present invention improves the S / N ratio of PCR products used in the transposon display method, and the intensity of peaks constituting the waveform data is strong, making it difficult to attenuate. It was. As a result, the longer part of the waveform pattern can be used for analysis, and individual differences in experimental results have been reduced. As a result, traits and related genes can be related more easily and objectively, and it has become possible to contribute to the development of better higher plants.
- FIG. 1 is a schematic view showing an outline of a DNA fragment amplification method according to the present invention.
- FIG. 2 is a diagram comparing changes in waveform data due to differences in the configuration of the PCR method.
- FIG. 3 is a diagram comparing heading time and culm length of MLR4 and MLR8 lines.
- FIG. 4 is a graph showing the distribution of panicle length of MLR4 and MLR8 lines.
- FIG. 5 is a graph showing the distribution of the number of spikes in MLR4 and MLR8 lines.
- FIG. 6 is an example of a diagram comparing the differences in peaks between individuals belonging to the same strain.
- FIG. 7 shows a base sequence near the mPing insertion position.
- FIG. 8 is a schematic view showing an outline of a conventional DNA fragment amplification method.
- the method for amplifying a DNA fragment which is particularly suitable for the present invention, is the same as the conventional method for amplifying a DNA fragment. (4) The second PCR steps are included in this order. Therefore, the details of each process will be described below with reference to FIG.
- the extraction method a known method without particular limitation can be used as long as the above conditions are satisfied.
- the CTAB method and the simple method can be cited.
- the extracted genomic DNA is shown schematically in Fig. 1 (a).
- the higher plant can be used without particular limitation as long as the mutant has been obtained to such an extent that the transposon display method can be conventionally applied.
- the transposon display method can be conventionally applied.
- Arabidopsis and morning glory that have already undergone genetic analysis are preferable.
- there is already a huge amount of base sequence information obtained by the genome project a small genome size, a transposon with few repetitive sequences, among cereals preferred. Rice is preferred because it has the advantages of applying the display method.
- transposon The base sequence of the transposon is known, and any transposon can be used in principle as long as it transposes by natural cultivation or tissue culture to destroy the gene.
- transposons with tens to thousands of copies per genome are preferred because of the maximization of the S / N ratio improvement that one-sided PCR brings.
- Use is the most efficient! / Specific examples include Tosl7, nDart, karma, and mPing.
- mPin has a relatively large number of copies in the genome (about 100 to several hundred copies), and exhibits moderate translocation activity (causes several to tens of copies per generation).
- Use of g is preferred.
- genomic DNA is partially digested with a restriction enzyme to form a DNA fragment, and an adapter capable of binding to the restriction enzyme recognition site is ligated to the DNA fragment.
- genomic DNA is partially digested into DNA fragments using restriction enzymes.
- a restriction enzyme a commercially available restriction enzyme that has a recognition site in a transposon can be used without particular limitation. It is preferable to use a 4-base recognition enzyme (such as Csp6I) that produces a small fragment of
- the restriction enzyme reaction may be carried out according to the reaction conditions required by the restriction enzyme to be used, such as buffer solution and temperature.
- the adapter is a double-stranded DNA of about 10 to 20 bases having a sequence corresponding to the recognition site of the restriction enzyme, which is synthesized by a commercially available DNA synthesizer or the like.
- the ligation may be performed in accordance with the reaction conditions required by the ligase used. Incidentally, partial digestion and ligation may be performed separately.
- Fig. 1 (b) shows a state before ligation
- Fig. 1 (c) shows a state after ligation
- the partial digest of genomic DNA is a mixture of one containing part of transposon T and one not containing 2 as shown in FIG. 1 (b).
- the adapter will ligate to either. Therefore, the ligation product is a mixture of ligation product 3 containing a part of transposon T and ligation product 4 not including this as shown in FIG. 1 (c).
- the ligation product 3 has a base sequence that specifically rings on transposon T. Therefore, in the first PCR step, the ligation product 3 is amplified by the number of cycles of the PCR reaction by PCR reaction starting from the ligation product 3 in the vertical shape and using the primer 1 as a starting point, and the PCR product 5 is generated.
- the ligation product 4 does not have a base sequence that specifically anneals to transposon T, and therefore the primer cannot be annealed in the first PCR step, and the DNA fragment 4 is not amplified. That is, the ratio of the PCR product 5 containing transposon T is greatly improved by the first PCR step.
- DNA fragment 4 and DNA fragment 6 are the same force. For convenience in illustration, different numbers are assigned.
- the primer length, base sequence, PCR reaction conditions specifically the temperature and reaction time of the thermal denaturation step, annealing step, extension step, the number of reaction cycles, etc. should be covered.
- the type can be adjusted while looking at the experimental results according to the primer.
- the proportion of PCR product 5 in the PCR product increases in proportion to the number of reaction cycles.
- the number of cycles for one-sided PCR can be determined as needed from the 20 cycles that provide a certain S / N ratio improvement effect to the 40 cycles that are the upper limit of DNA synthase normally used. I'll do it.
- PCR products 5 and 6 are made into a saddle shape, and labeled primer 3 that is the same as or inside the primer used in the first PCR step (below the transposon) and In this step, a two-sided PCR reaction is performed using primer 2 complementary to the adapter.
- both the labeled primer 3 and the primer 2 are used in the second PCR step, the labeled primer 3 and the primer 2 are annealed to the PCR product 5 as shown in Fig. 1 (d).
- a PCR reaction is performed to produce labeled PCR product 7.
- labeled primer 3 cannot be annealed to DNA fragment 6 and primer 2 is annealed at both ends, resulting in non-PCR product 8.
- both PCR products 5 and 6 are amplified. Therefore, between the first PCR step and the second PCR step, the ratio of the DNA fragment containing a part of the transposon and the DNA fragment not containing it is almost the same.
- the labeled primer 3 is a primer labeled with a labeling substance such as a fluorescent substance.
- the labeling substance and the labeling method can be used without particular limitation as long as they are known.
- the primer length, base sequence, and various PCR reaction conditions can be adjusted while looking at the experimental results as in the first PCR step.
- the ratio of labeled PCR product 7 in the PCR product is as follows.
- the (S / N ratio) is improved, the intensity of the peaks that make up the waveform data is strong, making it difficult to attenuate, and the longer part of the waveform pattern can be used for analysis. Therefore, the association between the presence / absence of a DNA fragment and the difference in trait, that is, the association between a certain trait and its related gene can be performed more easily and objectively than in the conventional method.
- the enzyme such as restriction enzyme, ligase, and DNA polymerase coexisting with the DNA fragment or PCR product is inactivated by removing, for example, phenol 'chloroform extraction. And a step of purifying these DNAs by ethanol precipitation or the like.
- an adapter was prepared by associating a synthetic oligo DNA, Csp6I_Al and Csp6I_A2.
- Table 1 shows the base sequences of the oligo DNA of adapters such as Csp6I_Al and Csp6 to A2, and primers described later.
- 10 ng of genomic DNA of each individual was placed in an Eppendorf tube, partially digested with the restriction enzyme Csp6I, and an adapter addition reaction was performed using T4 ligase (Ligation high, TOYO BO). After completion of the addition reaction, Csp6I and T4 ligase were inactivated, and the reaction product was purified and concentrated by ethanol precipitation and dissolved in 40 1 TE (pH 8.0) buffer.
- a part of the reaction product (1 H 1, DNA 250 pg) was collected for each individual, and the first PCR step was performed with the primer combinations shown in Table 2 (concentration: 25 0101/1).
- Srt-PI is an mPing-specific primer
- Srt-P3_D4 is labeled with a fluorescent dye (D4, BEC MAN COU LTER, USA), and is a primer specific for mPing. Is a primer complementary to the adapter.
- Table 3 shows the composition of the solution when the PCR reaction was performed, and Table 4 shows the PCR cycle of the PCR reaction.
- the PCR product of the first PCR step was diluted to 2.5 culture medium with ⁇ ( ⁇ 8 ⁇ 0) buffer, and this was used as a cage to perform the second PCR step using the primers shown in Table 2.
- the PCR product was purified by ethanol precipitation.
- the solution composition and reaction cycle when performing the PCR reaction were the same as in the first PCR step.
- the PCR product thus obtained was dissolved in a size marker (CEQ DNA Size Standard it-600 (BEC MAN COULTER, USA), labeled with Dl) 0.375 1 Solution (CEQ Sample Loading Solution (BEC MAN COULTER, USA) 30 1) and then applied to the sample plate of the first type DNA sequencer (CEQ 2000 Fragment Analysis System, BEC MAN COULTER, USA)
- the waveform data obtained by electrophoresis was converted to text data format using the computer software that came with the DNA sequencer, and the waveform data here refers to “fluorescence” at a specific “electrophoresis time”. Strength ".
- Next-generation individual lines (MLR lines, all 9 lines) of these individuals were transplanted to the field.
- the heading date was investigated for all plants planted, and the culm length, head length, number of ears, etc. were investigated approximately one week after heading.
- FIG. 3 to FIG. 5 show variations in heading date, culm length, head length, and number of heads of MLR4 and MLR8 belonging to the MLR line.
- Figure 3 shows a comparison of the heading date and culm length of these two lines.
- mutations of 30 days or more were observed on the heading date and 30 cm or more on the culm length.
- Figures 4 and 5 show the distribution of spike length and spike number, respectively.As shown in these figures, mutations of 8 to 22 cm were observed in the spike length, 1 to 16 mutations were observed.
- FIG. 6 is an example of a diagram comparing the differences in peaks between individuals belonging to the same strain.
- the data (partial) of MLR4-2 individuals that were the reference individuals in the MLR4 strain and MLR4-79 individuals (hereinafter referred to as comparative individuals, indicated by solid lines) different from that were compared. It is a result.
- the vertical axis indicates the fluorescence intensity (relative value) proportional to the amount of DNA fragment
- the horizontal axis indicates the size (bp) of the DNA fragment.
- the reference individual MLR4-2 has a peak and the comparative individual MLR4-79 has no peak. The location is indicated by (-), and the location where the reference individual has no peak and the comparative individual has a peak is indicated by (+).
- (1) indicates that mPing was inserted in the reference individual and the PCR product was amplified, or mPing was excised in the comparative individual and the PCR product was not amplified.
- (+) indicates that mPing was excised in the reference individual and PCR product was not amplified, or that mPing was inserted in the comparative individual and PCR product was amplified. That is, (1) and (+) show the insertion polymorphism of mPing between the reference individual and the comparative individual.
- DNA fragments related to the presence or absence of leaf hair were searched based on whether or not the presence or absence of the DNA fragment had a significant difference in the presence or absence of leaf hair. Specifically, a null hypothesis is established that there is no association between the presence or absence of leaf hair and a specific DNA fragment, the significance probability p is calculated, and the significance probability is 5% or less. determining the presence or absence of related by the X 2 test to determine (relationship. between the two) to reject the null hypothesis in. Table 7 shows the results that were found to be relevant. The p value in this table means the significance probability p.
- the relevant DNA fragment was searched for by t-test as in (5b).
- t-test as in (5b).
- 6 DNA fragments and 3 MLR8 were detected as candidates for DNA fragments related to mutations in panicle length.
- a 167 bp DNA fragment (see Table 10) related to panicle length and culm length shown in Example 2 was isolated by the transposon display method, and its nucleotide sequence was examined to search for related genes. Specifically, the procedure was as follows.
- the amplified DNA fragment was subjected to acrylamide gel electrophoresis, and a 167 bp amplified DNA fragment was excised from the gel to purify the DNA contained in the gel. Next, a PCR reaction was carried out using the Csp 6I-AP and Srt_P3 as primers, and the presence of the target DNA amplification fragment was confirmed. Furthermore, in order to clarify the base sequence of the amplified DNA fragment, the amplified DNA fragment was cloned into a sequencing vector (pGEM-T Easy).
- T7PR0M TAATACGACTCACTATAGGG (SEQ ID NO: 6)
- the mutant trait and the mPing insertion mutant gene are linked, and the gene of unknown function (Os07g0693000) is used to change the head length. It was revealed that it was a dominant gene in a short period of time and low effort compared to the conventional method.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
明 細 書 Specification
DNA断片の増幅方法 Amplification method of DNA fragment
技術分野 Technical field
[0001] この発明は、 DNA断片の増幅方法に関するものであり、特に、形質とそれに関連す る遺伝子とを迅速かつ客観的に関連づけるトランスポゾンディスプレイ法に使用する DNA断片の増幅方法に関するものである。 [0001] The present invention relates to a method for amplifying a DNA fragment, and more particularly to a method for amplifying a DNA fragment used in a transposon display method for rapidly and objectively associating a trait and a gene associated therewith.
背景技術 Background art
[0002] 分子生物学の進歩に伴って、人やマウスなどの動物に加えて、高等植物について もその全ゲノムの塩基配列が解析されるようになってきている。例えば、イネについて 、 International Rice Genome Sequencing Pro ject(IRGSP)によって、 2002年にはての ドラフト配列の解読が終了している。 [0002] With the progress of molecular biology, in addition to animals such as humans and mice, the base sequences of the whole genome of higher plants have been analyzed. For example, in the case of rice, the decoding of the draft sequence was completed in 2002 by the International Rice Genome Sequencing Project (IRGSP).
[0003] ただ、遺伝子組み換えによって、例えば乾燥 ·寒冷などの環境ストレスに対する耐 性を備えた植物や収穫量の多い植物を作り出すには、ゲノム DNAの全塩基配列を決 定するだけではなぐゲノム DNAに記載されている各遺伝子が植物の形質に与える 影響、すなわち各遺伝子がもつ機能についても解析しなければならない。そして、遺 伝子の機能を解析する方法の一つとして、以下に説明するトランスポゾンディスプレ ィ法が挙げられる。 [0003] However, in order to create plants with tolerance to environmental stresses such as drought and cold and plants with high yields by genetic recombination, genomic DNA is not limited to just determining the entire base sequence of genomic DNA. It is also necessary to analyze the effects of each gene described in the above on the traits of plants, that is, the functions of each gene. One method of analyzing the function of the gene is the transposon display method described below.
[0004] ここで、トランスポゾンとは、別名、転位性遺伝因子(transposable genetic element) 又は可動十生這 因子 (mobile genetic element, movable genetic element)と 呼はれ 、染色体 DNA上のある部位力、ら他の部位へ、ランダムに転位する性質を有する DNA 断片のことであり、転位先の遺伝子に揷入して遺伝子破壊等を起こすことが知られて いる。なお、イネで機能するトランスポゾンについては、 Tosl7、 karma (特許文献 1を 参照。)、mPing (特許文献 2及び非特許文献 1を参照。)などがすでに報告されてい [0004] Here, the transposon is also called a transposable genetic element or a mobile genetic element (mobile genetic element, movable genetic element). It is a DNA fragment that has the property of randomly translocating to other sites, and is known to cause gene disruption by inserting into the translocation target gene. As for transposons that function in rice, Tosl7, karma (see Patent Literature 1), mPing (see Patent Literature 2 and Non-Patent Literature 1) have already been reported.
[0005] また、トランスポゾンディスプレイ法とは、トランスポゾンの前記のような性質を利用し て遺伝子の機能を調べる方法であり、トランスポゾンによる遺伝子破壊とそれに伴う 形質の変化から、ある形質に関連する遺伝子を特定する方法であり、具体的には次 のようにして行なう(特許文献 2を参照。)。 [0005] In addition, the transposon display method is a method for examining the function of a gene by using the above-mentioned properties of the transposon, and a gene related to a certain trait is determined based on the gene disruption caused by the transposon and a change in the trait associated therewith. It is a method to identify, specifically (Refer to Patent Document 2).
[0006] まず、トランスポゾンの転位が原因で形質が変化した同系統の複数個体から、ゲノ ム DNAを抽出して、トランスポゾンの一部を含む DNA断片を増幅する。つぎに、増幅 した DNA断片を電気泳動して各個体のごとの波形データを得て、個体ごとの波形デ ータの違い、端的にはピークの有無の違い、を解析する。最後に、各個体のピークの 有無の違いと形質の違いとを比較することにより、ある特定の形質と特定の遺伝子と を関連づける。 [0006] First, genomic DNA is extracted from a plurality of individuals of the same strain whose traits have changed due to transposon transposition, and a DNA fragment containing a part of the transposon is amplified. Next, the amplified DNA fragments are electrophoresed to obtain waveform data for each individual, and the differences in the waveform data for each individual, in short, the presence or absence of peaks are analyzed. Finally, a specific trait is associated with a specific gene by comparing the difference in the presence or absence of the peak of each individual with the difference in the trait.
[0007] ここで、トランスポゾンの一部を含む DNA断片の増幅は、(l) DNA抽出工程、(2)ァ ダプター付加工程、(3) 1回目の PCR工程(以下、第 1の PCR工程)、(4) 2回目の PC R工程 (以下、第 2の PCR工程)の各工程に大きく分けることができる。なお、これらの 詳細については、模式図である図 8を使用して以下に説明する。 [0007] Here, amplification of a DNA fragment containing a part of the transposon consists of (l) DNA extraction step, (2) adapter addition step, (3) first PCR step (hereinafter referred to as first PCR step) (4) It can be roughly divided into each step of the second PCR step (hereinafter referred to as the second PCR step). Details of these will be described below with reference to FIG. 8, which is a schematic diagram.
[0008] (l) DNA抽出工程 [0008] (l) DNA extraction process
形質が異なる同系統の各個体から、簡便法 (非特許文献 2を参照。)などによってゲ ノム DNAを抽出する工程であり、図 8 (a)はある個体から抽出したゲノム DNAを模式的 に示している。なお、図中の Tはトランスポゾン、 IRは逆向き反復配列(Inverted Repea t)を意味している。 This is a process of extracting genomic DNA from individuals of the same strain with different traits by a simple method (see Non-Patent Document 2). Figure 8 (a) schematically shows genomic DNA extracted from an individual. Show. In the figure, T means a transposon, and IR means an inverted repeat.
[0009] (2)アダプター付加工程 [0009] (2) Adapter addition process
抽出したゲノム DNAを制限酵素により部分消化し、この制限酵素による認識部と結 合可能なオリゴマー DNA (アダプター)を前記部分消化 DNAにライゲーシヨンするェ 程である。なお、図 8 (b)ライゲーシヨン前の状態を示しており、図 8 (c)はライグーショ ン後の状態を示している。この図に示すように、ゲノム DNAの部分消化物はトランスポ ゾン Tの一部を含む部分消化物 1とこれを含まない部分消化物 2の混合物であり、ァ ダプターはその何れにもライゲーシヨンするため、ライゲーシヨン産物もトランスポゾン Tの一部を含むもの 3と含まな!/、もの 4の混合物である。 The extracted genomic DNA is partially digested with a restriction enzyme, and oligomer DNA (adapter) that can bind to the recognition site by this restriction enzyme is ligated to the partially digested DNA. Fig. 8 (b) shows the state before ligation, and Fig. 8 (c) shows the state after ligation. As shown in this figure, the partial digest of genomic DNA is a mixture of partial digest 1 that contains a part of transposon T and partial digest 2 that does not contain transposon T, and the adapter ligates to either of them. Ligation products are also a mixture of 3 with and without 4!
[0010] (3) 1回目の PCR工程 [0010] (3) First PCR step
1回目の PCR工程は、図 8 (c)に示すように、トランスポゾン Tの塩基配列の一部に 特異的なプライマー 1及び前記アダプターに相補的なプライマー 2の 2つのプライマ 一を使用して両側 PCR反応を行なう工程であって、図 8 (d)に示すような PCR産物を 得る工程である。ここで、ライゲーシヨン産物 3にはプライマー 1及びプライマー 2がァ ニーリングして PCR産物 5が生成する。これに対して、ライゲーシヨン産物 4にはプライ マー 1がアニーリングできないため、両端にプライマー 2がアニーリングして PCR産物 6が生成する。なお、 DNA断片 4と DNA断片 6は同一のものである力 図示する上で の便宜上から別の番号を付した。 As shown in Fig. 8 (c), the first PCR step is performed on both sides using two primers: primer 1 specific for a part of the base sequence of transposon T and primer 2 complementary to the adapter. A PCR reaction step, where a PCR product as shown in Fig. 8 (d) It is a process to obtain. Here, primer product 1 and primer 2 are annealed to ligation product 3 to produce PCR product 5. In contrast, primer 1 cannot be annealed to ligation product 4, so primer 2 is annealed at both ends to produce PCR product 6. The DNA fragment 4 and the DNA fragment 6 have the same force. For convenience in illustration, different numbers are assigned.
[0011] (4) 2回目の?0¾ェ程 [0011] (4) Second time? About 0¾
2回目の PCR工程は、図 8 (d)に示すように、 PCR産物 5及び 6を铸型とし、トランスポ ゾン Tの一部に特異的な標識プライマー 3及び前記アダプターに相補的なプライマ 一 2を使用して PCR反応を行なう工程である。なお、トランスポゾンの一部を含む PCR 産物 5には標識プライマー 3とプライマー 2とがアニーリングして標識 PCR産物 7が生 成する。これに対して、 PCR産物 6にはプライマー 3がアニーリングできないため、両 端にプライマー 2がアニーリングして PCR産物 8が生成する。 As shown in Fig. 8 (d), the second PCR step consists of PCR products 5 and 6 in a saddle shape, a labeled primer 3 specific for a part of transposon T and a primer complementary to the adapter 2 Is a step of performing a PCR reaction using The PCR product 5 containing a part of the transposon is annealed with labeled primer 3 and primer 2 to generate labeled PCR product 7. In contrast, primer 3 cannot be annealed to PCR product 6, so primer 2 is annealed at both ends to produce PCR product 8.
[0012] ここで図 8 (e)に示すように、増幅した DNA断片は標識 PCR産物 7と非標識 PCR産物 [0012] Here, as shown in FIG. 8 (e), the amplified DNA fragments are labeled PCR product 7 and unlabeled PCR product.
8の混合物である。また、ライゲーシヨン産物 3、 4の何れも両端にアダプターを備えて いること、第 1の PCR工程、第 2の PCR反応の何れの工程においてもこのアダプター に相補的なプライマーであるプライマー 2を使用していることから、 PCR産物中の標識 PCR産物 7と非標識 PCR産物 8との割合は、トランスポゾン Tの一部を含む DNA断片 1 とこれを含まない DNA断片 2の割合とほぼ同一である。 8 mixture. In addition, both ligation products 3 and 4 must have adapters at both ends, and primer 2 that is complementary to this adapter is used in both the first PCR step and the second PCR reaction. Therefore, the ratio of labeled PCR product 7 to unlabeled PCR product 8 in the PCR product is almost the same as the ratio of DNA fragment 1 containing a part of transposon T and DNA fragment 2 not containing this.
[0013] このようにして得られた DNA断片は、前記のように、電気泳動、波形データの解析、 形質と遺伝子との関連づけに使用する。なお、電気泳動によって得られた波形デー タの解析は、従来、実験者の経験と勘に基づいて手作業で行われていた。そのため 、多大な時間 ·労力を必要とし、解析結果には個人差があり客観的ではなかった。そ こで、発明者らは、異なる電気泳動によって得られた波形データを容易かつ客観的 に比較するために、「和歌山県地域結集型共同研究事業」によって「イネトランスポゾ ン解析支援システム」を作成し利用して!/、る (特許文献 3を参照)。 [0013] As described above, the DNA fragment thus obtained is used for electrophoresis, analysis of waveform data, and correlation between a trait and a gene. Conventionally, analysis of waveform data obtained by electrophoresis has been performed manually based on the experience and intuition of the experimenter. Therefore, it took a lot of time and labor, and the analysis results were not objective because there were individual differences. In order to easily and objectively compare the waveform data obtained by different electrophoresis, the inventors have developed the “Rice Transposon Analysis Support System” through the “Wakayama Prefectural Community Research Project”. Create and use! /, Ru (see Patent Document 3).
[0014] このシステムは、サイズマーカーと PCR産物とを混合して電気泳動することによって 、波形データを構成する泳動時間を増幅産物の大きさ (塩基数)に変換し、波形デー タの蛍光強度を定量化することができる。そのため、異なる電気泳動基づく波形デー タをあた力、も同じ電気泳動によって得られたように補正し、波形データの比較を容易 かつ客観的に行なうことができる。 [0014] In this system, the size marker and the PCR product are mixed and electrophoresed to convert the migration time constituting the waveform data into the size (number of bases) of the amplified product, and the fluorescence intensity of the waveform data. Can be quantified. Therefore, waveform data based on different electrophoresis It is possible to easily and objectively compare the waveform data by correcting the force as applied by the same electrophoresis.
[0015] 以上のように、トランスポゾンディスプレイ法は、ある形質とそれに関連する遺伝子と を関連づける有用な方法であり、特に前記のシステムを使用することによりその有用 性はより向上した。 [0015] As described above, the transposon display method is a useful method for associating a certain trait with a gene associated therewith, and its usefulness has been further improved by using the above-described system in particular.
[0016] しかし、波形データを構成する各ピークの強度が弱くかつ減衰が激しいため、得ら れた波形データのうちの 300bpより長い部分については、電気的ノイズと電気泳動に よるピークと力 S区別できず、事実上解析に利用できないとの問題点があった。また、 各ピークの強度が弱く検出が不安定であるために、実験者によって結果に差異を生 じ、一定の結果を安定して出せるようになるまでにはかなりの習熟を要するとの問題 点もあった。 [0016] However, since the intensity of each peak constituting the waveform data is weak and the attenuation is intense, the portion of the obtained waveform data longer than 300 bp is subjected to the peak and force S due to electrical noise and electrophoresis. There was a problem that they could not be distinguished and could not be used for analysis. In addition, since the intensity of each peak is weak and the detection is unstable, there is a problem that the experimenter makes a difference in the results, and a considerable amount of skill is required before stable results can be obtained. There was also.
特許文献 1 :特願第 2002— 369691号公報 Patent Document 1: Japanese Patent Application No. 2002-369691
特許文献 2 :米国特許第 6, 420, 117号公報 Patent Document 2: U.S. Pat.No. 6,420,117
特許文献 3:特願 2005— 237438号 Patent Document 3: Japanese Patent Application No. 2005-237438
非特許文献 1:中崎ら(Nakazaki,T.), イネゲノム中でのトランスポゾンの移動(Mobiliz ation or transposon in the rice genome) ,ィ、 ナヤ一 (Nature; ,421(2003), p.170—172 非特許文献 2 :吉田晋弥、塩飽邦子、 "米粒からの簡易 DNA抽出法と RAPDによる酒 米の品種判別"、 [online] ,中国農業試験場平成 10年度 研究成果情報、 [2006 年 5月 10日検索]、インターネット < URL:http:〃 www.affrc.go.jp/seika/data#cgk/hlO /seibuti cgkgSOCM.html > Non-Patent Document 1: Nakazaki et al. (Nakazaki, T.), Movement of transposon in the rice genome (Nature;, 421 (2003), p.170-172) Non-Patent Document 2: Junya Yoshida, Kuniko Shio, "Simple rice extraction method from rice grain and discrimination of sake rice varieties by RAPD", [online], Chinese Agricultural Experiment Station, 1998 research result information, [May 10, 2006 Search], Internet <URL: http: 〃 www.affrc.go.jp/seika/data#cgk/hlO / seibuti cgkgSOCM.html>
発明の開示 Disclosure of the invention
[0017] そこで、この発明は、トランスポゾンディスプレイ法に使用する DNA断片の増幅方法 であって、 DNA断片を電気泳動して得られる波形データのピークの強度が強くて減 衰し難ぐ波形パターンのより長い部分についても解析に使用できるとともに、実験結 果の個人差が少ない DNA断片の増幅方法を提供することを課題とする。 [0017] Therefore, the present invention is a method for amplifying a DNA fragment used in the transposon display method, wherein the waveform data obtained by electrophoresis of the DNA fragment has a waveform pattern that has a strong peak intensity and is difficult to attenuate. It is an object of the present invention to provide a method for amplifying a DNA fragment that can be used for analysis of a longer part and that has little individual difference in experimental results.
[0018] 発明者は、波形データを構成するピークの強度が弱くかつ減衰が激しレ、理由につ いて検討した。その結果、発明者は、第 1の PCR工程、第 2の PCR工程において、標 識 PCR産物 7だけなぐ非標識 PCR産物 8も同じ割合で増幅していることから、 PCR反 応に利用するプライマーや核酸モノマー (d匿)などが非標識 PCR産物 8の増幅に 無駄に消費され、標識 PCR産物 7の増幅がサイクル数に見合った分だけ行なわれて いないことが原因である、と考えた。 [0018] The inventor has examined the reason why the intensity of the peak constituting the waveform data is weak and the attenuation is intense. As a result, the inventor amplified the same amount of unlabeled PCR product 8 as well as labeled PCR product 7 in the first PCR step and second PCR step. This is because primers and nucleic acid monomers (d) that are used at the same time are wasted for amplification of the unlabeled PCR product 8, and the amplification of the labeled PCR product 7 is not performed in proportion to the number of cycles. I thought.
[0019] そこで、発明者は、標識 PCR産物だけを増幅すること、すなわち PCR産物中の標識 PCR産物 7の割合(以下、 S/N比)を向上することにより、前記問題点を解決することに ついて検討した。その結果、トランスポゾンディスプレイに使用する DNAを増幅する際 に、 2つのプライマーを使用する通常の両側 PCR反応を 2回行なうのではなぐ 1回目 の PCR反応をトランスポゾンの塩基配列に特異的なプライマーだけを使用する片側 P CR法に代えることにより、前記 S/N比が大きく向上することに気づいた。 [0019] Therefore, the inventor solves the above problem by amplifying only the labeled PCR product, that is, by improving the ratio of the labeled PCR product 7 in the PCR product (hereinafter, S / N ratio). Was examined. As a result, when amplifying the DNA used for transposon display, instead of performing the normal double-sided PCR reaction using two primers twice, the first PCR reaction should be performed using only primers specific to the base sequence of the transposon. It was noticed that the S / N ratio was greatly improved by replacing the one-side PCR method used.
[0020] すなわち、この発明の DNA断片の増幅方法は、(1)高等植物の細胞からゲノム DN Aを抽出する DNA抽出工程と、(2)ゲノム DNAを制限酵素によって部分消化して DNA 断片とし、この DNA断片に前記制限酵素の認識部位と結合可能なアダプターをライ ゲーシヨンするアダプター付加工程と、 (3)前記アダプターがライゲーシヨンされ DNA 断片を铸型とし、前記トランスポゾンに特異的なプライマーのみを使用する片側 PCR 法によって、 DNA断片を増幅する第 1の PCR工程と、(4)前記第 1の PCR工程によつ て増幅した DNA断片を铸型とし、前記トランスポゾンに特異的な標識プライマー及び 前記アダプターに相補的なプライマーを使用する両側 PCR法によって、 DNA断片を 増幅する第 2の PCR工程と、をこの順序で含むものである。 [0020] That is, the method for amplifying a DNA fragment of the present invention comprises (1) a DNA extraction step for extracting genomic DNA from cells of a higher plant, and (2) partial digestion of genomic DNA with a restriction enzyme to obtain a DNA fragment. An adapter addition step of ligating an adapter capable of binding to the restriction enzyme recognition site to the DNA fragment, and (3) using the primer specific to the transposon by ligating the adapter into a vertical DNA fragment. A first PCR step for amplifying a DNA fragment by a one-side PCR method, and (4) a DNA fragment amplified by the first PCR step in a saddle shape, and a labeled primer specific for the transposon and the This includes a second PCR step in this order that amplifies the DNA fragment by a two-sided PCR method using primers complementary to the adapter.
[0021] この発明に力、かる DNA断片の増幅方法によって、トランスポゾンディスプレイ法に使 用する PCR産物の S/N比が向上し、波形データを構成するピークの強度が強くて減 衰し難くなつた。これにより、波形パターンのより長い部分についても解析に使用でき るようになり、実験結果の個人差が少なくなつた。そのため、形質とそれに関連する遺 伝子とをより容易かつ客観的に関連づけることができ、より優れた高等植物の育成に 貢献すること力できるようになった。 [0021] The power of the present invention, the amplification method of DNA fragments, improves the S / N ratio of PCR products used in the transposon display method, and the intensity of peaks constituting the waveform data is strong, making it difficult to attenuate. It was. As a result, the longer part of the waveform pattern can be used for analysis, and individual differences in experimental results have been reduced. As a result, traits and related genes can be related more easily and objectively, and it has become possible to contribute to the development of better higher plants.
図面の簡単な説明 Brief Description of Drawings
[0022] [図 1]この発明にかかる DNA断片の増幅方法の概要を示す概略図である。 FIG. 1 is a schematic view showing an outline of a DNA fragment amplification method according to the present invention.
[図 2]PCR法の構成の違いによる波形データの変化を比較した図である。 FIG. 2 is a diagram comparing changes in waveform data due to differences in the configuration of the PCR method.
[図 3]MLR4及び MLR8系統の出穂期及び稈長を比較した図である。 [図 4]MLR4及び MLR8系統の穂長の分布を示す図である。 FIG. 3 is a diagram comparing heading time and culm length of MLR4 and MLR8 lines. FIG. 4 is a graph showing the distribution of panicle length of MLR4 and MLR8 lines.
[図 5]MLR4及び MLR8系統の穂数の分布を示す図である。 FIG. 5 is a graph showing the distribution of the number of spikes in MLR4 and MLR8 lines.
[図 6]同系統に属する個体同士のピークの違いを比較した図の一例である。 FIG. 6 is an example of a diagram comparing the differences in peaks between individuals belonging to the same strain.
[図 7]mPing揷入位置付近の塩基配列を示す図である。 FIG. 7 shows a base sequence near the mPing insertion position.
[図 8]従来の DNA断片の増幅方法の概要を示す概略図である FIG. 8 is a schematic view showing an outline of a conventional DNA fragment amplification method.
発明を実施するための最良の形態 BEST MODE FOR CARRYING OUT THE INVENTION
[0023] この発明に力、かる DNA断片の増幅方法は、従来からある DNA断片の増幅方法と同 様、(l) DNA抽出工程、(2)アダプター付加工程、(3)第 1の PCR工程、(4)第 2の PC R工程の各工程をこの順番で含んでいる。そこで、各工程の詳細について、その概要 を示す図である図 1などに基づいて以下に説明する。 [0023] The method for amplifying a DNA fragment, which is particularly suitable for the present invention, is the same as the conventional method for amplifying a DNA fragment. (4) The second PCR steps are included in this order. Therefore, the details of each process will be described below with reference to FIG.
[0024] (l) DNA抽出工程 [0024] (l) DNA extraction process
形質が異なる同系統の高等植物の各個体から、切断部位の少ない、すなわち充分 に長いゲノム DNAを抽出する工程である。また、抽出方法としては、前記条件を満た せば特に限定することなぐ公知の方法を使用することができる。具体的には、 CTAB 法や簡便法 (非特許文献 2を参照。)などを挙げること力 Sできる。なお、抽出したゲノム DNAを図 1 (a)に模式的に示す。 This is a process of extracting genomic DNA with a small number of cleavage sites, that is, sufficiently long, from each individual of a higher plant of the same line with different traits. As the extraction method, a known method without particular limitation can be used as long as the above conditions are satisfied. Specifically, the CTAB method and the simple method (see Non-Patent Document 2) can be cited. The extracted genomic DNA is shown schematically in Fig. 1 (a).
[0025] ここで、前記高等植物としては、従来からトランスポゾンディスプレイ法が適用できる 程度に変異体が得られているものであれば、特に限定することなく使用できる。具体 的には、学術的な観点から考えると、すでに遺伝子解析が進んでいるシロイヌナズナ やアサガオが好ましい。また、経済的な観点から考えると、穀物類が好ましぐそのな かでもゲノムプロジェクトによって得られた膨大な塩基配列情報が既に存在すること、 ゲノムサイズが少なレ、こと、繰り返し配列が少なくトランスポゾンディスプレイ法を適用 しゃすレ、ことなどの利点を備えてレ、ることから、イネが好ましレ、。 [0025] Here, the higher plant can be used without particular limitation as long as the mutant has been obtained to such an extent that the transposon display method can be conventionally applied. Specifically, from an academic point of view, Arabidopsis and morning glory that have already undergone genetic analysis are preferable. Also, from an economic point of view, there is already a huge amount of base sequence information obtained by the genome project, a small genome size, a transposon with few repetitive sequences, among cereals preferred. Rice is preferred because it has the advantages of applying the display method.
[0026] また、前記トランスポゾンとしては、その塩基配列が判明しており、自然栽培や組織 培養などによって転位して遺伝子を破壊するものであれば原則的に利用することが できる。ただ、片側 PCRがもたらす S/N比向上のメリットを最大限に利用するといぅ理 由から、ゲノムあたりのコピー数が数十から数千のトランスポゾンが好ましぐ 100から 1 000程度のトランスポゾンを用いると最も効率がよ!/、。 [0027] 具体的には、前記の Tosl7、 nDart、 karma, mPingが挙げられる。なかでも、ゲノム内 にある程度多くのコピー数を持ち(100から千数百コピー程度)、自然栽培条件下でも 適度な転位活性(一世代あたり数コピーから数十コピーの転位を起こす)を示す mPin gの利用が好ましい。 [0026] The base sequence of the transposon is known, and any transposon can be used in principle as long as it transposes by natural cultivation or tissue culture to destroy the gene. However, transposons with tens to thousands of copies per genome are preferred because of the maximization of the S / N ratio improvement that one-sided PCR brings. Use is the most efficient! / Specific examples include Tosl7, nDart, karma, and mPing. Among them, mPin has a relatively large number of copies in the genome (about 100 to several hundred copies), and exhibits moderate translocation activity (causes several to tens of copies per generation). Use of g is preferred.
[0028] (2)アダプターの付加 [0028] (2) Addition of adapter
ゲノム DNAを制限酵素によって部分消化して DNA断片とし、この DNA断片に前記 制限酵素の認識部位と結合可能なアダプターをライゲーシヨンする工程である。 In this step, genomic DNA is partially digested with a restriction enzyme to form a DNA fragment, and an adapter capable of binding to the restriction enzyme recognition site is ligated to the DNA fragment.
[0029] まず、ゲノム DNAを制限酵素によって DNA断片に部分消化する。ここで、制限酵素 としては、市販の制限酵素のうち、トランスポゾン中にその認識部位が存在するもの であれば特に限定することなく使用できる力 S、確率的に認識部位が多ぐ主として 600 bp以下の小さな断片を生じる 4塩基認識酵素(Csp6Iなど)の使用が好ましい。また、 制限酵素反応は、使用する制限酵素の要求する緩衝液、温度などの反応条件に沿 つてネ亍なえばよい。 [0029] First, genomic DNA is partially digested into DNA fragments using restriction enzymes. Here, as a restriction enzyme, a commercially available restriction enzyme that has a recognition site in a transposon can be used without particular limitation. It is preferable to use a 4-base recognition enzyme (such as Csp6I) that produces a small fragment of In addition, the restriction enzyme reaction may be carried out according to the reaction conditions required by the restriction enzyme to be used, such as buffer solution and temperature.
[0030] つぎに、部分消化した DNA断片とアダプターとを混合して、 DNA断片の端部にライ ゲーシヨンする。アダプタ一としては、前記の制限酵素の認識部位に対応する配列を 備えた 10〜20塩基程度の二本鎖 DNAであり、これは市販の DNA合成装置などにより 合成したものである。また、ライゲーシヨンは使用するライゲースが要求する反応条件 に沿って行なえばよい。ちなみに、部分消化とライゲーシヨンとは別々でなぐ同時に 行ってもよい。 [0030] Next, the partially digested DNA fragment and the adapter are mixed and ligated to the ends of the DNA fragment. The adapter is a double-stranded DNA of about 10 to 20 bases having a sequence corresponding to the recognition site of the restriction enzyme, which is synthesized by a commercially available DNA synthesizer or the like. The ligation may be performed in accordance with the reaction conditions required by the ligase used. Incidentally, partial digestion and ligation may be performed separately.
[0031] なお、図 1 (b)はライゲーシヨン前の状態を示しており、図 1 (c)はライゲーシヨン後の 状態を示している。ここで、ゲノム DNAの部分消化物は、図 1 (b)に示すように、トラン スポゾン Tの一部を含むもの 1と、含まないもの 2との混合物である。また、アダプター はそのどちらにもライゲーシヨンする。そのため、ライゲーシヨン産物は、図 1 (c)に示 すように、トランスポゾン Tの一部を含むライゲーシヨン産物 3とこれを含まな!/、ライゲ ーシヨン産物 4の混合物となる。 [0031] Fig. 1 (b) shows a state before ligation, and Fig. 1 (c) shows a state after ligation. Here, the partial digest of genomic DNA is a mixture of one containing part of transposon T and one not containing 2 as shown in FIG. 1 (b). The adapter will ligate to either. Therefore, the ligation product is a mixture of ligation product 3 containing a part of transposon T and ligation product 4 not including this as shown in FIG. 1 (c).
[0032] (3)第 1の PCR工程 [0032] (3) First PCR step
ライゲーシヨン産物 3、 4を铸型に、トランスポゾン Tに特異的にアニーリングするプラ イマ一 1だけを使用して、片側 PCR反応を行なう工程である。 [0033] 図 1 (c)に示すように、ライゲーシヨン産物 3はトランスポゾン Tに特異的にァユーリン グする塩基配列を備えている。そのため、第 1の PCR工程において、ライゲーシヨン産 物 3を铸型とし、プライマー 1を起点とする PCR反応によって、 PCR反応のサイクル数 分だけライゲーシヨン産物 3が増幅し、 PCR産物 5が生成する。これに対して、ライゲ ーシヨン産物 4はトランスポゾン Tに特異的にアニーリングする塩基配列を備えていな いため、第 1の PCR工程においては、プライマーがアニーリングできず、 DNA断片 4が 増幅することはない。すなわち、第 1の PCR工程によって、トランスポゾン Tを含む PCR 産物 5の割合は大きく向上する。なお、 DNA断片 4と DNA断片 6は同一のものである 力 図示する上での便宜上から別の番号を付した。 This is a one-sided PCR reaction using ligation products 3 and 4 in a bowl shape and using only a primer that specifically anneals to transposon T. [0033] As shown in Fig. 1 (c), the ligation product 3 has a base sequence that specifically rings on transposon T. Therefore, in the first PCR step, the ligation product 3 is amplified by the number of cycles of the PCR reaction by PCR reaction starting from the ligation product 3 in the vertical shape and using the primer 1 as a starting point, and the PCR product 5 is generated. On the other hand, the ligation product 4 does not have a base sequence that specifically anneals to transposon T, and therefore the primer cannot be annealed in the first PCR step, and the DNA fragment 4 is not amplified. That is, the ratio of the PCR product 5 containing transposon T is greatly improved by the first PCR step. DNA fragment 4 and DNA fragment 6 are the same force. For convenience in illustration, different numbers are assigned.
[0034] また、プライマーの長さ、塩基配列、 PCR反応の条件、具体的には熱変性工程、ァ ニーリング工程、伸張工程の温度や反応時間、反応サイクル数などについては、対 象となる铸型ゃプライマーに応じて実験結果を見ながら調整すればよい。ただ、反応 サイクル数に比例して、 PCR産物中の PCR産物 5の割合 (S/N比)は向上する。なお、 片側 PCRのサイクル数は、ある程度の S/N比向上効果が得られる 20サイクルから、通 常用いられる DNA合成酵素の上限である 40サイクルまでの範囲で必要に応じて定め ること力 Sでさる。 [0034] Further, the primer length, base sequence, PCR reaction conditions, specifically the temperature and reaction time of the thermal denaturation step, annealing step, extension step, the number of reaction cycles, etc. should be covered. The type can be adjusted while looking at the experimental results according to the primer. However, the proportion of PCR product 5 in the PCR product (S / N ratio) increases in proportion to the number of reaction cycles. The number of cycles for one-sided PCR can be determined as needed from the 20 cycles that provide a certain S / N ratio improvement effect to the 40 cycles that are the upper limit of DNA synthase normally used. I'll do it.
[0035] (4)第 2の PCR工程 [0035] (4) Second PCR step
図 1 (d)に示すように、 PCR産物 5、 6を铸型にして、第 1の PCR工程に使用したプラ イマ一と同一又はその内側(トランスポゾン下側)に特異的な標識プライマー 3と、ァダ プターに相補的なプライマー 2とを使用して両側 PCR反応を行なう工程である。 As shown in Fig. 1 (d), PCR products 5 and 6 are made into a saddle shape, and labeled primer 3 that is the same as or inside the primer used in the first PCR step (below the transposon) and In this step, a two-sided PCR reaction is performed using primer 2 complementary to the adapter.
[0036] 第 2の PCR工程では、標識プライマー 3及びプライマー 2の両方を使用するため、図 1 (d)に示すように、 PCR産物 5には標識プライマー 3とプライマー 2とがアニーリングし て両側 PCR反応が行なわれ、標識 PCR産物 7が生成する。これに対して、 DNA断片 6 に標識プライマー 3はアニーリングできず、両端にプライマー 2がアニーリングするの で非 PCR産物 8が生成する。このように、第 2の PCR工程では、 PCR産物 5、 6何れも が増幅する。そのため、第 1の PCR工程と第 2の PCR工程との間で、トランスポゾン丁の 一部を含む DNA断片とこれを含まない DNA断片の割合はほぼ同一である。 [0036] Since both the labeled primer 3 and the primer 2 are used in the second PCR step, the labeled primer 3 and the primer 2 are annealed to the PCR product 5 as shown in Fig. 1 (d). A PCR reaction is performed to produce labeled PCR product 7. In contrast, labeled primer 3 cannot be annealed to DNA fragment 6 and primer 2 is annealed at both ends, resulting in non-PCR product 8. Thus, in the second PCR step, both PCR products 5 and 6 are amplified. Therefore, between the first PCR step and the second PCR step, the ratio of the DNA fragment containing a part of the transposon and the DNA fragment not containing it is almost the same.
[0037] なお、標識プライマー 3は、蛍光物質などの標識物質によって標識しているプライマ 一であり、標識物質及び標識の方法は公知のものであれば特に限定することなく使 用できる。また、プライマーの長さ、塩基配列、 PCR反応の各種条件については、第 1 の PCR工程と同様に実験結果を見ながら調整すればよい。 [0037] The labeled primer 3 is a primer labeled with a labeling substance such as a fluorescent substance. The labeling substance and the labeling method can be used without particular limitation as long as they are known. The primer length, base sequence, and various PCR reaction conditions can be adjusted while looking at the experimental results as in the first PCR step.
[0038] 以上のように、この発明の DNA断片の増幅方法は、第 1の PCR工程においてトラン スポゾン Tの一部を含む DNA断片のみを増幅するので、 PCR産物中の標識 PCR産物 7の割合(S/N比)が向上し、波形データを構成するピークの強度が強くて減衰し難く なり、波形パターンのより長い部分についても解析に使用できるようになる。そのため 、 DNA断片の有無と形質の違いとの関連付け、すなわち、ある形質とそれに関連する 遺伝子の関連づけを、従来法に比べてより容易、且つ客観的に行なうことができる。 [0038] As described above, since the DNA fragment amplification method of the present invention amplifies only a DNA fragment containing a part of transposon T in the first PCR step, the ratio of labeled PCR product 7 in the PCR product is as follows. The (S / N ratio) is improved, the intensity of the peaks that make up the waveform data is strong, making it difficult to attenuate, and the longer part of the waveform pattern can be used for analysis. Therefore, the association between the presence / absence of a DNA fragment and the difference in trait, that is, the association between a certain trait and its related gene can be performed more easily and objectively than in the conventional method.
[0039] なお、この発明は前記実施の形態に限定されるわけではなぐ特許請求の範囲に 記載の技術的範囲内でさまざまな変更を加えることができる。例えば、必要に応じて 他の工程を加えてもよい。具体的には、標識プライマーを使用する PCR反応前に、片 側 PCR反応や、片側 PCR反応と両側 PCR反応からなる PCR反応セットを加えてもよ!/、 。このように片側 PCR反応を複数回繰り返し行なうことによって、前記 S/N比をより向上 すること力 Sでさる。 It should be noted that the present invention is not limited to the above-described embodiments, and various modifications can be made within the technical scope described in the claims. For example, other steps may be added as necessary. Specifically, before a PCR reaction using a labeled primer, you can add a one-sided PCR reaction or a PCR reaction set consisting of a one-sided PCR reaction and a two-sided PCR reaction! /,. In this way, the S / N ratio can be further improved by repeating the one-side PCR reaction a plurality of times.
[0040] また、前記の各工程の間に、必要に応じてフエノール'クロ口ホルム抽出などにより、 DNA断片や PCR産物と共在する制限酵素、ライゲース、 DNAポリメラーゼなどの酵素 を失活 '除去する工程、エタノール沈殿などによりこれら DNAを精製する工程を含ん でいてもよい。 [0040] Also, during each of the above steps, the enzyme such as restriction enzyme, ligase, and DNA polymerase coexisting with the DNA fragment or PCR product is inactivated by removing, for example, phenol 'chloroform extraction. And a step of purifying these DNAs by ethanol precipitation or the like.
[0041] 以下、この発明について実施例に基づいてより詳細に説明する力 この発明の特 許請求の範囲は如何なる意味においても制限されるものではない。 [0041] Hereinafter, the present invention will be described in more detail based on examples. The scope of claims of the present invention is not limited in any way.
実施例 1 Example 1
[0042] トランスポゾンディスプレイ法にお!/、て、片側 PCR反応によるトランスポゾン Tの一部 を含む DNA断片の増幅効率の向上効果を調べた。具体的には、(a)第 1の PCR工程 のみを片側 PCR反応とした場合、 (b)第 2の PCR工程のみ片側 PCR反応とした場合、 (c)片側 PCR反応を 1回だけ行なう場合について、(d)従来法による結果との比較を fiなった。 [0042] In the transposon display method, the effect of improving the amplification efficiency of a DNA fragment containing a part of transposon T by one-side PCR reaction was investigated. Specifically, (a) When only the first PCR step is a one-sided PCR reaction, (b) When only the second PCR step is a one-sided PCR reaction, (c) When one-sided PCR reaction is performed only once (D) The comparison with the result by the conventional method became fi.
[0043] (1)植物材料および DNA抽出 2004年度に圃場に栽植したイネ細粒系統 M294の 5個体の葉から、個体別に簡便 法(非特許文献 2を参照)によって抽出した DNAを試料として使用した。 [0043] (1) Plant material and DNA extraction DNA extracted from the leaves of five rice fine lines M294 planted in the field in 2004 by a simple method (see Non-Patent Document 2) was used as a sample.
[0044] (2)アダプター付加工程 [0044] (2) Adapter addition process
まず、合成オリゴ DNA、 Csp6I_Alと Csp6I_A2を会合させてアダプターを作成した。 なお、 Csp6I_Alと Csp6ト A2等のアダプターや後述するプライマーのオリゴ DNAの塩 基配列を表 1に示す。つぎに、各個体のゲノム DNA 10ngをエツペンドルフチューブに 入れ、制限酵素 Csp6Iにより部分消化するとともに、 T4リガーゼ(Ligation high, TOYO BO)を用いてアダプターの付加反応を行った。付加反応の完了後、 Csp6Iおよび T4リ ガーゼを失活させ、エタノール沈殿により反応生成物を精製'濃縮して 40 1の TE(pH 8.0)緩衝液に溶解した。 First, an adapter was prepared by associating a synthetic oligo DNA, Csp6I_Al and Csp6I_A2. Table 1 shows the base sequences of the oligo DNA of adapters such as Csp6I_Al and Csp6 to A2, and primers described later. Next, 10 ng of genomic DNA of each individual was placed in an Eppendorf tube, partially digested with the restriction enzyme Csp6I, and an adapter addition reaction was performed using T4 ligase (Ligation high, TOYO BO). After completion of the addition reaction, Csp6I and T4 ligase were inactivated, and the reaction product was purified and concentrated by ethanol precipitation and dissolved in 40 1 TE (pH 8.0) buffer.
[0045] [表 1] オリ ゴ DNA 塩基配列 [0045] [Table 1] Oligo DNA nucleotide sequence
Csp6 I -A 1 TAGTCAGGACTGAT (配歹 IJ番号 1 ) Csp6 I -A 1 TAGTCAGGACTGAT (Major IJ number 1)
Csp6 I -A2 GACGATCAGTCCTGAC (配列番号 2 ) Csp6 I -A2 GACGATCAGTCCTGAC (SEQ ID NO: 2)
Srt-Pl TAGTCTTGGAAACGTCAA (配列番号 3 ) Srt-Pl TAGTCTTGGAAACGTCAA (SEQ ID NO: 3)
Srt-P3-D4 TCATTTGAGAGAAGATGGTA (配列番号 4 ) Srt-P3-D4 TCATTTGAGAGAAGATGGTA (SEQ ID NO: 4)
Csp6 I -AP GACGATCAGTCCTGACTAC (配列番号 5 ) Csp6 I -AP GACGATCAGTCCTGACTAC (SEQ ID NO: 5)
[0046] (3)第 1の PCR工程 [0046] (3) First PCR step
個体ごとに反応産物の一部 (1 H 1、 DNA 250pg)を分取して、表 2に示すプライマー の組み合わせ(濃度は 25 0101/ 1)で第 1の PCR工程を行なった。なお、表 2中の Srt -PIは mPing特異的プライマーであり、 Srt-P3_D4は蛍光色素(D4、 BEC MAN COU LTER,USA)で標識し、かつ mPingに特異的なプライマーであり、 Csp6ト APはアダプタ 一に相補的なプライマーである。また、 PCR反応を行った際の溶液組成を表 3に示す とともに、 PCR反応の PCRサイクノレを表 4に示す。 A part of the reaction product (1 H 1, DNA 250 pg) was collected for each individual, and the first PCR step was performed with the primer combinations shown in Table 2 (concentration: 25 0101/1). In Table 2, Srt-PI is an mPing-specific primer, Srt-P3_D4 is labeled with a fluorescent dye (D4, BEC MAN COU LTER, USA), and is a primer specific for mPing. Is a primer complementary to the adapter. Table 3 shows the composition of the solution when the PCR reaction was performed, and Table 4 shows the PCR cycle of the PCR reaction.
[0047] [表 2] 使用した 試験区 [0047] [Table 2] Test area used
プライマー a b c d Primer a b c d
Srt-Pl 0.06 a 1 0.06 /i 1 0.06 a 1 第 1の PCR Srt- P3-D4 Srt-Pl 0.06 a 1 0.06 / i 1 0.06 a 1 First PCR Srt- P3-D4
Csp6 I - AP 0.06μ 1 0.06μ 1 Csp6 I-AP 0.06μ 1 0.06μ 1
Srt- P3-D4 0.06 a 1 0.06μ 1 0.06 a 1 第 2の PCR Srt- P3-D4 0.06 a 1 0.06μ 1 0.06 a 1 Second PCR
Csp6 I -AP 0.06μ 1 0.06μ 1 Csp6 I -AP 0.06μ 1 0.06μ 1
[0048] [表 3] 第 1の PCR 第 2の PCR [0048] [Table 3] First PCR Second PCR
10 X PCRバッファー 1.00μ 1 1.00 μ 1 10 X PCR buffer 1.00μ 1 1.00 μ 1
2mM dNTPs 1.00 μ 1 1.00 μ 1 2 mM dNTPs 1.00 μ 1 1.00 μ 1
2omM MgS04 0.40μ 1 0.40 1 プライマー (25pmol//i 1) 0.06/; 1ま oたは 0.12 /i 1 0.06 1または 0. \2,ι \2omM MgS0 4 0.40μ 1 0.40 1 Primer (25 pmol//i 1) 0.06 /; 1 or 0.12 / i 1 0.06 1 or 0. \ 2, ι \
KOD-Plus (1U/W1) 0.20 oμ 1 0.20W 1 KOD-Plus (1U / W 1) 0.20 oμ 1 0.20 W 1
H O 6.84 μ 1または 6.78// 1 6.84 a 1または 6.78/x 1 鎢型 UNA 0.50μ 1 (250pg) 0.50μ 1 H O 6.84 μ 1 or 6.78 // 1 6.84 a 1 or 6.78 / x 1 Vertical UNA 0.50μ 1 (250pg) 0.50μ 1
総量 Total amount
[0049] [表 4] o [0049] [Table 4] o
PCRサイクル PCR cycle
94°C 2分 o 94 ° C 2 minutes o
94°C 15秒 94 ° C 15 seconds
58°C 1分 > 30サイクノレ 58 ° C 1 minute> 30 cyclore
68°C 1分 68 ° C 1 minute
リ Re
68°C 1分 68 ° C 1 minute
4°C 保存 4 ° C storage
[0050] (4)第 2の PCR工程 [0050] (4) Second PCR step
第 1の PCR工程の PCR産物を ΤΕ(ρΗ8·0)緩衝液で 2.5培に希釈し、これを铸型として 表 2に示すプライマーを用いて第 2の PCR工程を行った。そして、 PCR産物をエタノー ル沈殿法により精製した。なお、 PCR反応を行なう際の溶液組成及び反応サイクルは 第 1の PCR工程と同じであった。 The PCR product of the first PCR step was diluted to 2.5 culture medium with ΤΕ (ρΗ8 · 0) buffer, and this was used as a cage to perform the second PCR step using the primers shown in Table 2. The PCR product was purified by ethanol precipitation. The solution composition and reaction cycle when performing the PCR reaction were the same as in the first PCR step.
[0051] (5)電気泳動 [0051] (5) Electrophoresis
このようにして得られた PCR産物を、サイズマーカー(CEQ DNA Size Standard it- 600(BEC MAN COULTER, USA)、 Dlにより標識済み。) 0.375 1とサンプル溶解溶 液(CEQ Sample Loading Solution (BEC MAN COULTER,USA) 30 1との混合液に 溶解したのち、キヤビラリ一型 DNAシーケンサー (CEQ 2000 Fragment Analysis Syste m,BEC MAN COULTER, USA)のサンプルプレートにアプライして電気泳動した。電 気泳動によって得た波形データは、 DNAシーケンサー付属のコンピュータソフトによ つてテキストデータ形式に変換した。なお、ここでいう波形データとは特定の「泳動時 間」での「蛍光強度」である。 The PCR product thus obtained was dissolved in a size marker (CEQ DNA Size Standard it-600 (BEC MAN COULTER, USA), labeled with Dl) 0.375 1 Solution (CEQ Sample Loading Solution (BEC MAN COULTER, USA) 30 1) and then applied to the sample plate of the first type DNA sequencer (CEQ 2000 Fragment Analysis System, BEC MAN COULTER, USA) The waveform data obtained by electrophoresis was converted to text data format using the computer software that came with the DNA sequencer, and the waveform data here refers to “fluorescence” at a specific “electrophoresis time”. Strength ".
[0052] (6)波形データ解析 [0052] (6) Waveform data analysis
このテキストデータを前記「イネトランスポゾン解析支援システム」に入力し、同シス テムの「変異比較」により(a)から(c)によって得られた各波形データと従来法によつ て得られた波形データとの比較を行った。その結果を図 2の(a)から(c)に示す。なお 、図中の実線は(a)から(c)、点線は(d)従来法による波形データを示している。 This text data is input to the “Rice Transposon Analysis Support System”, and the waveform data obtained by (a) to (c) and the waveform obtained by the conventional method by the “variation comparison” of the system. Comparison with the data was performed. The results are shown in Fig. 2 (a) to (c). In the figure, solid lines indicate waveform data from (a) to (c), and dotted lines indicate (d) waveform data by the conventional method.
[0053] (7)実験結果 [0053] (7) Experimental results
(a)第 1の PCR工程のみを片側 PCR法とした場合には、図 2 (a)に示すように、その 蛍光強度の最大値は 2万程度になり、 80bpから 600bpの広範囲に渡ってピークを観察 すること力 Sできた。また、従来法による PCR産物と比べて蛍光強度の減衰は緩やかで あり、より大きな増幅産物が得られる傾向にあった。なお、この方法は、従来法とは異 なり実験者による成功率の差異が少なぐ実験技術の習得も容易であった。具体的 には、初心者でも数日で操作を完了し、 5反復行なっても結果が安定していた。また 、従来法の場合には 8名が取り組んで、ある一定以上の結果が得られたのは 1名だけ であった。これに対して、この方法では 7名が取り組んで 7名とも満足のいく結果を得 ること力 Sでさた。 (a) When only the first PCR step is a one-sided PCR method, the maximum value of the fluorescence intensity is about 20,000, as shown in Fig. 2 (a), over a wide range from 80 bp to 600 bp. I was able to observe the peak. In addition, the fluorescence intensity decayed more slowly than the PCR product obtained by the conventional method, and a larger amplified product tended to be obtained. Unlike the conventional method, this method made it easy to learn experimental techniques with little difference in the success rate by the experimenter. Specifically, even beginners completed the operation within a few days, and the results were stable even after 5 iterations. In the case of the conventional method, eight people worked on it, and only one person obtained a result above a certain level. On the other hand, with this method, 7 people worked and 7 people were able to obtain satisfactory results.
[0054] (b)第 2の PCR工程のみを片側 PCR法とした場合には、図 2 (b)に示すように、全範 囲に渡って蛍光強度が減少し、特に 200bp以上では著しく減少した。これは、第 1の P CR工程を行なった際に、トランスポゾンを含まな!/、DNA断片が多数増幅された結果、 第 2の PCR行程に際してプライマーおよびモノマーが著しく消費されるためであると考 えられる。また、第 1の PCR工程では図 1 (c)の目的の断片 3と不要な断片 4の比は変 わらないため、第 2の PCR工程において目的の断片 3が PCR産物の指数関数的増幅 に優先的に関わることもないと考えられる。 [0055] (c)片側 PCR反応を 1回だけ行なった場合には、図 2 (c)に示すように、従来法によ る PCR産物よりも一見減衰が少なかった。片側 PCR反応が大きな断片を増幅するの に効果的であることを示している。しかしながら、この方法では mPing特異的プライマ 一を 1種類し力、使用していないため、ターゲット配列の絞り込みが不十分になる可能 性が考えられる。実際、(a)の増幅断片数よりも(c)の増幅断片数が多いのはこのた めであると考えられる。 [0054] (b) When only the second PCR step is a one-sided PCR method, the fluorescence intensity decreases over the entire range as shown in Fig. 2 (b), particularly at 200 bp or more. did. This is thought to be due to the significant consumption of primers and monomers during the second PCR step as a result of the amplification of many DNA fragments that did not contain transposons during the first PCR step! available. In the first PCR step, the ratio of target fragment 3 and unwanted fragment 4 in Fig. 1 (c) does not change, so target fragment 3 is used for exponential amplification of PCR products in the second PCR step. It is thought that there is no priority. [0055] (c) When the one-side PCR reaction was performed only once, as shown in FIG. 2 (c), the apparent attenuation was smaller than that of the PCR product obtained by the conventional method. One-sided PCR reactions are shown to be effective in amplifying large fragments. However, since this method does not use a single mPing-specific primer, it may be possible to narrow down the target sequence. In fact, this is why the number of amplified fragments in (c) is larger than the number of amplified fragments in (a).
[0056] 以上の結果から、(a)第 1の PCR工程のみを片側 PCRとした場合には、トランスポゾ ン Τの一部を含む PCR産物を従来法よりも高い割合で得られることがわかった。 実施例 2 [0056] From the above results, it was found that (a) when only the first PCR step is a one-sided PCR, a PCR product containing a part of the transposon Τ can be obtained at a higher rate than the conventional method. . Example 2
[0057] この発明の DNA増幅方法を利用したトランスポゾンディスプレイ法によって、経済形 質に関連する遺伝子を含む DNA断片の特定を以下に試みた。具体的には、(5a)葉 毛の有無、(5b)穂数、(5c)穂長、(5d)稈長と関連する DNA断片の特定を試みた。 [0057] By the transposon display method using the DNA amplification method of the present invention, an attempt was made to identify a DNA fragment containing a gene related to economic properties. Specifically, we attempted to identify DNA fragments associated with (5a) leaf presence, (5b) number of spikes, (5c) spike length, and (5d) pod length.
[0058] (1)栽培試験と DNAの抽出 [0058] (1) Cultivation test and DNA extraction
2004年に圃場に栽培した ML細粒系統の中から、非細粒、かつ gold-hullの形質を 持った個体を得た。このような個体は細粒個体と正常粒個体との他殖では生じな!/、こ とから、 mPingの転移によって誘発された突然変異体であると推定することができる。 Individuals with non-fine-grained gold-hull traits were obtained from ML fine-grained lines grown in the field in 2004. Such individuals do not occur in the breeding of fine-grained and normal-grained individuals! /, Thus it can be deduced that they are mutants induced by mPing metastasis.
[0059] これら個体の個体別次代系統 (MLR系統、全 9系統)を圃場に移植した。栽植した全 個体について出穂日を調査し、出穂よりおよそ 1週間後に稈長、穂長、穂数等を調査 した。 [0059] Next-generation individual lines (MLR lines, all 9 lines) of these individuals were transplanted to the field. The heading date was investigated for all plants planted, and the culm length, head length, number of ears, etc. were investigated approximately one week after heading.
[0060] すべての形質の調査後、個体ごとに止葉の一つ下の葉を手で採取し、個体別に実 施例 1に記載の簡便法によりゲノム DNAを抽出した。 [0060] After all the traits were examined, the leaf immediately below the leaf was manually collected for each individual, and genomic DNA was extracted by the simple method described in Example 1 for each individual.
[0061] (2)トランスポゾンディスプレイ及び波形データ解析 [0061] (2) Transposon display and waveform data analysis
得られた各個体のゲノム DNAを使用して、実施例 1と同様にしてトランスポゾンディ スプレイ法及び波形データの解析を行なった。なお、 PCR反応の PCRサイクルのみ表 5に示すものに変更した。そして、発見した変異と mPing揷入多型との間の関連を検 定し、突然変異を起こした形質に関連する mPingコピーを検出した。 Using the obtained genomic DNA of each individual, the transposon display method and waveform data analysis were performed in the same manner as in Example 1. Only the PCR cycle of the PCR reaction was changed to that shown in Table 5. We then examined the association between the found mutation and the mPing insertion polymorphism and detected mPing copies associated with the mutated trait.
[0062] [表 5] PCRサイクル [0062] [Table 5] PCR cycle
94°C 2分 94 ° C 2 minutes
94°C 15秒 、 94 ° C for 15 seconds,
58°C 30秒 30サイク 58 ° C 30 seconds 30 cycles
68°C 1分 68 ° C 1 minute
68°C 1分 68 ° C 1 minute
4°C 保存 4 ° C storage
[0063] (3)栽培試験の結果 [0063] (3) Results of cultivation test
まず、全 9系統の MLR系統において全個体の形質を調査したところ、全系統におい て出穂期ゃ稈長などの形質に変異が認められた。例えば、 MLR系統に属する MLR4 及び MLR8の出穂日、稈長、穂長、穂数における変異を図 3から図 5に示す。図 3はこ れら 2系統の出穂日及び稈長を比較した図であり、この図に示すように、出穂日にお いては 30日以上、稈長においては 30cm以上の変異が認められた。図 4、図 5は、そ れぞれ穂長、穂数の分布を示す図であるが、これらの図に示すように、穂長には 8か ら 22cmの変異が認められ、穂数には 1から 16本の変異が認められた。以上の結果か ら、これら 2系統においては、遺伝的変異が存在することが明らかになった。 全ての個体において PCR産物の増幅を示すピークが確認でき、同系統に属する各 個体から生じたピークの違いも確認することができた。例えば、 MLR8の場合には得ら れた全 79個体、 MLR4の場合には不正交雑の指標である gold-hull形質が欠落して!/ヽ た 8個体及びデータが得られなかった 4個体を除く 70個体を使用することにより、何れ の系統においても 80bpから 600bpまでの範囲に PCR産物の増幅を示すピークが確認 でき、各個体間のピークの違レ、も確認できた。 First, when the traits of all individuals were investigated in all 9 MLR lines, mutations were observed in traits such as heading length and cocoon length in all lines. For example, FIG. 3 to FIG. 5 show variations in heading date, culm length, head length, and number of heads of MLR4 and MLR8 belonging to the MLR line. Figure 3 shows a comparison of the heading date and culm length of these two lines. As shown in this figure, mutations of 30 days or more were observed on the heading date and 30 cm or more on the culm length. Figures 4 and 5 show the distribution of spike length and spike number, respectively.As shown in these figures, mutations of 8 to 22 cm were observed in the spike length, 1 to 16 mutations were observed. From the above results, it was clarified that genetic variation exists in these two strains. Peaks indicating amplification of PCR products were confirmed in all individuals, and differences in peaks generated from individuals belonging to the same strain were also confirmed. For example, in the case of MLR8, all 79 individuals obtained, in the case of MLR4, the gold-hull trait, which is an indicator of illegal crossing, is missing! / ヽ 8 individuals and 4 individuals for whom data were not obtained. By using the excluding 70 individuals, it was possible to confirm the peak indicating amplification of the PCR product in the range from 80 bp to 600 bp in any strain, and to confirm the difference in peak between each individual.
[0065] 図 6は、同系統に属する個体同士のピークの違いを比較した図の一例である。具体 的には、 MLR4系統において基準個体とした MLR4-2個体(点線で示す。)とそれとは 異なる MLR4-79個体(以下、比較個体、実線で示す。)とのデータ(一部分)を比較し た結果である。なお、この図において、縦軸は DNA断片の量に比例する蛍光強度( 相対値)を示し、横軸は DNA断片の大きさ (bp)を示している。また、この図においては 、基準個体である MLR4-2にはピークがあり比較個体である MLR4-79にピークがない 箇所は (-)で示しており、基準個体にピークがなく比較個体にピークがある箇所を (+ )で示している。 FIG. 6 is an example of a diagram comparing the differences in peaks between individuals belonging to the same strain. Specifically, the data (partial) of MLR4-2 individuals (indicated by dotted lines) that were the reference individuals in the MLR4 strain and MLR4-79 individuals (hereinafter referred to as comparative individuals, indicated by solid lines) different from that were compared. It is a result. In this figure, the vertical axis indicates the fluorescence intensity (relative value) proportional to the amount of DNA fragment, and the horizontal axis indicates the size (bp) of the DNA fragment. In this figure, the reference individual MLR4-2 has a peak and the comparative individual MLR4-79 has no peak. The location is indicated by (-), and the location where the reference individual has no peak and the comparative individual has a peak is indicated by (+).
[0066] 言換えると、(一)は、基準個体において mPingが揷入され PCR産物が増幅したか、 又は比較個体において mPingが切り出されて PCR産物が増幅しなかったことを示して いる。反対に、(+ )は、基準個体において mPingが切り出されて PCR産物が増幅しな かったか、又は比較個体にお!/、て mPingが揷入され PCR産物が増幅したことを示して いる。すなわち、(一)および (+ )は基準個体と比較個体との間における mPingの揷入 多型を示している。 [0066] In other words, (1) indicates that mPing was inserted in the reference individual and the PCR product was amplified, or mPing was excised in the comparative individual and the PCR product was not amplified. On the other hand, (+) indicates that mPing was excised in the reference individual and PCR product was not amplified, or that mPing was inserted in the comparative individual and PCR product was amplified. That is, (1) and (+) show the insertion polymorphism of mPing between the reference individual and the comparative individual.
[0067] このように、トランスポゾンディスプレイを行なった結果、基準個体と比較個体とのピ ークの増減、すなわち mPingの揷入多型について一覧表にまとめることができた。 ML R4についてまとめたものの一部を表 6に示す。なお、基準個体には MLR4-2を使用し た。 [0067] Thus, as a result of transposon display, it was possible to summarize the increase / decrease in the peak between the reference individual and the comparison individual, that is, the mPing insertion polymorphism. Table 6 shows a part of the summary of ML R4. MLR4-2 was used as the reference individual.
[0068] [表 6] [0068] [Table 6]
[0069] (5)形質データと揷入多型との統合 [0069] (5) Integration of trait data and insertion polymorphism
圃場調査から得られた形質データと mPingの揷入多型とを比較し、変異形質と共分 離する mPingの揷入多型を調べた。その結果、(5a)葉毛の有無、(5b)穂数、(5c)穂 長、(5d)稈長の 4形質について、変異の有無と 5%水準で有意な相関をもつ mPingの 揷入多型を発見した。 Comparison of trait data obtained from field surveys and mPing insertion polymorphism We investigated the insertion polymorphism of mPing. As a result, (5a) presence or absence of leaf hair, (5b) number of spikes, (5c) spike length, and (5d) spike length, mPing, which has a significant correlation at 5% level with the presence or absence of mutation Found a type.
[0070] (5a)葉毛の有無 [0070] (5a) Presence or absence of leaf hair
葉毛の有無に関連する DNA断片を、その DNA断片の有無が葉毛の有無に有意差 を与えるか否かに基づいて、探した。具体的には、葉毛の有無とある特定の DNA断 片との間には関連がないとの帰無仮説を立て、有意確率 pを計算し、有意確率が有 意水準 5%以下の場合には前記帰無仮説を棄却する(両者の間には関係がある。 )と 判断する X 2検定により関連の有無を判断した。その結果、関連があると認められたも のを表 7に示す。なお、この表の p値は前記有意確率 pを意味している。 DNA fragments related to the presence or absence of leaf hair were searched based on whether or not the presence or absence of the DNA fragment had a significant difference in the presence or absence of leaf hair. Specifically, a null hypothesis is established that there is no association between the presence or absence of leaf hair and a specific DNA fragment, the significance probability p is calculated, and the significance probability is 5% or less. determining the presence or absence of related by the X 2 test to determine (relationship. between the two) to reject the null hypothesis in. Table 7 shows the results that were found to be relevant. The p value in this table means the significance probability p.
[0071] [表 7] [0071] [Table 7]
DNA断片 葉毛の有無 DNA fragment With or without leaf hair
系統 個体数 P値 Strain Number P Number
(bp) 有り 無し (bp) Yes No
MLR4 有 50 38 12 MLR4 Yes 50 38 12
120 0. 0000 120 0. 0000
20 19 20 19
有 62 31 31 Yes 62 31 31
103 0. 0117 103 0. 0117
有 61 37 24 Yes 61 37 24
227 0. 0302 227 0. 0302
MLR8 有 65 56 MLR8 Yes 65 56
120 0. 0000 120 0. 0000
13 13 13 13
有 64 49 15 Yes 64 49 15
142 0. 0218 142 0. 0218
4ε 15 4ε 15
有 54 42 11 Yes 54 42 11
238 0. 0348 238 0. 0348
4ε 24 13 12 4ε 24 13 12
[0072] この表から分かるように、葉毛の有無に関連がある DNA断片の候補力 S、 MLR4で 3つ 、 MLR8で 3つ検出できた。これらの中でも 120bpの断片は両系統において検出でき、 p値もほぼ 0%に低かった。このことから、 mPingがこの遺伝子座から切り出されること により無毛性が発現したと考えることができる。 [0072] As can be seen from this table, three DNA fragment candidate forces S, MLR4 and 3 MLR8 were detected, which are related to the presence or absence of leaf hair. Of these, the 120 bp fragment was detectable in both strains, and the p-value was as low as 0%. From this, it can be considered that hairlessness was expressed by excising mPing from this locus.
[0073] (5b)穂数 [0073] (5b) Number of ears
穂数と関連のある特定の DNA断片を、その DNA断片の有無が穂数に有意差を与 えるか否かに基づいて、 t検定により探した。具体的には、まず、穂数とある特定の DN A断片との間には関連がないとの帰無仮説を立て、特定の DNA断片を持つ組と持た ない組について穂数の平均値、不偏分散をそれぞれ計算し、それらに基づいて指標 tを計算した。つぎに、指標 tと自由度から有意確率 pを求め、有意確率が有意水準 5% 以下の場合には前記帰無仮説を棄却する(両者の間には関係がある。 )と判断した。 その結果、穂数の有無に関連がある DNA断片の候補力 表 8に示すように、 MLR4で 4つ、 MLR8で 3つ検出された。なお、この表の p値は前記有意確率 pを意味している。 Specific DNA fragments associated with the number of spikes were sought by t-test based on whether the presence or absence of the DNA fragment significantly affected the number of spikes. Specifically, first, the number of spikes and a specific DN A null hypothesis that there is no association with the A fragment was calculated, and the average number of ears and the unbiased variance were calculated for the pair with and without the specific DNA fragment, respectively, and the index t was calculated based on these values. Calculated. Next, the significance probability p was obtained from the index t and the degree of freedom. When the significance probability was 5% or less, the null hypothesis was rejected (there is a relationship between the two). As a result, as shown in Table 8, four DNA fragments and three MLR8 were detected as candidates for DNA fragments related to the presence or absence of the number of spikes. The p value in this table means the significance probability p.
[表 8] [Table 8]
UNA断片 穂数 UNA fragments
系統 個体数 1 Strain Number of individuals 1
(bp) 平均 不偏分散 (bp) Mean Unbiased variance
MLR4 有 8. 25 17. 93 MLR4 Yes 8. 25 17. 93
297 0. 0087 297 0. 0087
62 5. 68 5. 1 1 62 5. 68 5. 1 1
有 10 4. 30 5. 57 Yes 10 4. 30 5. 57
604 0. 0300 604 0. 0300
無 60 6. 25 6. 80 None 60 6. 25 6. 80
有 10 7. 60 14. 04 Yes 10 7. 60 14. 04
98 0. 0347 98 0. 0347
無 60 5. 70 5. 54 None 60 5. 70 5. 54
有 64 6. 17 6. 94 Yes 64 6. 17 6. 94
346 0. 0377 346 0. 0377
無 6 3. 38 3. 37 None 6 3. 38 3. 37
MI.R8 有 71 6. 90 4. 26 MI.R8 Yes 71 6. 90 4. 26
550 550
無 8 8. 88 4. 41 None 8 8. 88 4. 41
有 57 7. 40 4. 60 Yes 57 7. 40 4. 60
155 0. 0425 155 0. 0425
無 11 6. 32 3. 85 None 11 6. 32 3. 85
有 21 7. 90 3. 19 Yes 21 7. 90 3. 19
195 0. 0439 195 0. 0439
無 58 6. 81 4. 82 No 58 6. 81 4. 82
[0075] (5c)穂長 [0075] (5c) Hocho
穂長についても、(5b)と同様に t検定により関連のある特定の DNA断片を探した。 その結果、穂長の変異に関連がある DNA断片の候補力 表 9に示すように、 MLR4に 6つ、 MLR8に 3つ検出できた。 As for the panicle length, the relevant DNA fragment was searched for by t-test as in (5b). As a result, as shown in Table 9, 6 DNA fragments and 3 MLR8 were detected as candidates for DNA fragments related to mutations in panicle length.
[0076] [表 9] DNA断片 個体数 [0076] [Table 9] DNA fragment Number of individuals
(bp) 平均 不偏分散 (bp) Mean Unbiased variance
MLR 47 17. 37 5. bo MLR 47 17. 37 5.bo
243 0. 0013 243 0. 0013
23 15. 21 8. 06 23 15. 21 8. 06
有 13 18. 65 2. 94 Yes 13 18. 65 2. 94
280 0. 280 0.
67 16. 21 Ί. 'άό' 67 16. 21 Ί. 'Άό'
有 47 丄 7, 13 7. 57 Yes 47 丄 7, 13 7. 57
122 0. 0198 122 0. 0198
無 2.2 丄 5. 51 5. 25 None 2.2 丄 5. 51 5. 25
有 7 18. 61 5. 52 Yes 7 18. 61 5. 52
251 0. 0441 251 0. 0441
無 63 16. 44 7. 20 No 63 16. 44 7. 20
有 55 17. 00 7. 03 Yes 55 17. 00 7. 03
368 0. 0450 368 0. 0450
無 15 15. 42 7. 14 None 15 15. 42 7. 14
ΪΗ 24 17. 5(i . 78 ΪΗ 24 17.5 (i. 78
330 0. 0451 330 0. 0451
無 46 16. 19 6. 17 No 46 16. 19 6. 17
MLK 有 18. ϋ'ό MLK Yes 18. ϋ'ό
1 16. 64 10. 82 1 16. 64 10. 82
有 23 16. 8 7. 91 Yes 23 16. 8 7. 91
394 0. 0318 394 0. 0318
無 5β 18. 07 4. 59 No 5β 18. 07 4. 59
有 G7 17. 47 6. 06 Yes G7 17. 47 6. 06
95 0. 0474 95 0. 0474
無 66 19. 29 3. 36 No 66 19. 29 3. 36
[0077] (5d)稈長 [0077] (5d) Chief
稈長についても、(5b)と同様に t検定により関連のある特定の DNA断片を探した。 その結果、穂長の変異に関連がある DNA断片の候補力 表 10に示すように、 MLR4 に 5つ、 MLR8に 4つ検出できた。 As for the culm length, similar to (5b), we searched for specific DNA fragments related by t-test. As a result, as shown in Table 10, 5 DNA fragments and 4 MLR8 were detected as candidates for DNA fragments related to ear length mutation.
[0078] [表 10] [0078] [Table 10]
DNA断片 DNA fragment
系統 侗体数 P値 System Number of enclosures P value
(bp) 平均 不偏分散 (bp) Mean Unbiased variance
MLRd 有 51 57. 43 50. 93 MLRd Yes 51 57. 43 50. 93
406 0. 0064 406 0. 0064
nt 19 62. 53 29. 71 nt 19 62. 53 29. 71
有 58 57. 88 50. 11 Yes 58 57. 88 50. 11
109 0. 0138 109 0. 0138
VI 63. 33 ^ϋ. 24 VI 63. 33 ^ ϋ. 24
有 61 59. 49 46. 25 Yes 61 59. 49 46. 25
177 0. 0356 177 0. 0356
9 54. 22 55. 94 9 54. 22 55. 94
有 24 56. 42 58. 08 Yes 24 56. 42 58. 08
330 U. Ού 330 U. Ού
46 60. 07 42. 11 46 60. 07 42. 11
29 60. 83 37. 86 29 60. 83 37. 86
290 0. 0440 290 0. 0440
41 54. 49 41 54. 49
MLR8 有 74 61. 66 49. 68 MLR8 Yes 74 61. 66 49. 68
326 U. UUo 326 U. UUo
lot 5 71. 20 82. 70 lot 5 71. 20 82. 70
有 60 63. 35 51. 11 Yes 60 63. 35 51. 11
167 0. 0214 167 0. 0214
19 58. 84 59. 70 19 58. 84 59. 70
有 13 66. 38 57. 42 Yes 13 66. 38 57. 42
346 0. 0293 346 0. 0293
66 61. 45 52. 77 66 61. 45 52. 77
有 61 48. 38 Yes 61 48. 38
406 0. 0345 406 0. 0345
18 59. 00 72. 47 18 59. 00 72. 47
[0079] このように、この発明の DNA増幅方法により PCR産物の S/N比が向上するため、波 形パターンのより広い範囲を解析に使用できるようになった。また、実験者による実験 結果のバラツキが減ったため、トランスポゾンディスプレイ法による形質と遺伝子との 関連づけが、より容易かつ客観的にできるようになった。 [0079] Thus, since the S / N ratio of the PCR product is improved by the DNA amplification method of the present invention, a wider range of waveform patterns can be used for analysis. In addition, since the variation in the experiment results by the experimenter has decreased, it has become easier and more objective to correlate traits and genes by the transposon display method.
実施例 3 Example 3
[0080] 実施例 2で示された穂長と稈長に関係する 167bpの DNA断片(表 10を参照)をトラン スポゾンディスプレイ法により単離してその塩基配列を調べ、関連する遺伝子を探索 した。具体的には次のような手順で行った。 [0080] A 167 bp DNA fragment (see Table 10) related to panicle length and culm length shown in Example 2 was isolated by the transposon display method, and its nucleotide sequence was examined to search for related genes. Specifically, the procedure was as follows.
プライ Csp6I_APの 3'端に A T Gおよび Cの何れ力、 1塩基を付加した選択プラ イマ一と Srt-P3_D4と使用し、 Use Srt-P3_D4 and a selection primer with one base added to ATG and C at the 3 'end of ply Csp6I_AP,
つて、 167bpの DNA断片を増幅した。プライ Csp6I_APの代りに選択プライ を 使用した理由は、 167bpの DNA増幅断片の近傍にはサイズの異なる DNA断片が存在 し、 目的の DNA断片だけを増幅するのが困難だからである。 Therefore, a 167 bp DNA fragment was amplified. The reason for using the selection ply instead of the ply Csp6I_AP is that there are DNA fragments of different sizes near the 167 bp amplified DNA fragment, and it is difficult to amplify only the target DNA fragment.
[0082] その結果をキヤピラリー電気泳動により確認したところ、 目的とする 167bpの DNA断 片の増幅は、 Aを付加した選択プライ を使用した場合にのみ確認できた。一方、 167bp近傍に存在したサイズの異なる DNA断片は、この PCR反応では増幅されなか つた。このように、選択プライマーを使用することによって、 167bpの DNA断片だけを 増幅することができた。 [0082] The results were confirmed by capillary electrophoresis. As a result, amplification of the objective 167 bp DNA fragment could be confirmed only when the selection ply to which A was added was used. on the other hand, DNA fragments of different sizes that existed around 167 bp were not amplified in this PCR reaction. Thus, by using the selection primer, only a 167 bp DNA fragment could be amplified.
[0083] (2) DNA増幅断片の精製とサブクローニング [0083] (2) Purification and subcloning of amplified DNA fragments
DNA増幅断片のアクリルアミドゲル電気泳動を行い、ゲルから 167bpの DNA増幅断 片を切り出して、ゲルに含まれる DNAを精製した。つぎに、この DNAを铸型にして Csp 6I-APと Srt_P3をプライマーとして使用する PCR反応を行い、 目的とする DNA増幅断 片の存在を確認した。さらに、 DNA増幅断片の塩基配列を明らかにするため、 DNA 増幅断片をシークェンシングベクター(pGEM-T Easy)内にクローニングした。 The amplified DNA fragment was subjected to acrylamide gel electrophoresis, and a 167 bp amplified DNA fragment was excised from the gel to purify the DNA contained in the gel. Next, a PCR reaction was carried out using the Csp 6I-AP and Srt_P3 as primers, and the presence of the target DNA amplification fragment was confirmed. Furthermore, in order to clarify the base sequence of the amplified DNA fragment, the amplified DNA fragment was cloned into a sequencing vector (pGEM-T Easy).
[0084] (3) DNA増幅断片の塩基配列及び mPing揷入位置に隣接する塩基配列の決定 [0084] (3) Determination of the base sequence of the amplified DNA fragment and the base sequence adjacent to the mPing insertion position
シークェンシングベクターのクローニングサイトを挟むように設計したプライマー(T7 PROM及び SP6PROM、表 11を参照)を使用して、クローニングサイト内に挿入された 目的断片の塩基配列を決定した。また、得られた塩基配列から、シークェンシングべ クタ一配列および mPing配列を取り除!/、て、 mPingが揷入された位置に隣接する配列 を調べた。 Using primers designed to sandwich the cloning vector cloning site (T7 PROM and SP6PROM, see Table 11), the nucleotide sequence of the target fragment inserted into the cloning site was determined. Further, the sequencing vector sequence and mPing sequence were removed from the obtained base sequence! / And the sequence adjacent to the position where mPing was inserted was examined.
[0085] [表 11] オリ ゴ DNA 塩基配列 [0085] [Table 11] Oligo DNA nucleotide sequence
T7PR0M TAATACGACTCACTATAGGG (配列番号 6 ) T7PR0M TAATACGACTCACTATAGGG (SEQ ID NO: 6)
SP6PR0M ATTTAGGTGACACTATAGAA (配列番号 7 ) SP6PR0M ATTTAGGTGACACTATAGAA (SEQ ID NO: 7)
[0086] その結果、図 7に示すように 92bpの塩基配列(配列番号 8)が得られた。なお、図 7 の囲み線部はプライマー由来の配歹 !J、下線部は mPing配列(部分)を示している。 As a result, a 92 bp base sequence (SEQ ID NO: 8) was obtained as shown in FIG. In FIG. 7, the boxed line portion indicates the primer-derived arrangement! J, and the underlined portion indicates the mPing sequence (part).
[0087] (4)突然変異の原因遺伝子の探索 [0087] (4) Search for the causative gene of the mutation
Ίネ染色体塩 目 ti歹1 Jァータへース (http://www.shigen.nig.ac.jp/rice/oryzabase/to p/top.jsp)で前記塩基配列を検索したところ、 mPingは、第 7染色体(AP008213、全長 29644043bp)の長椀末端近く(29430773bp)に揷入されていること、その直後 170bpに は蛋白質キナーゼドメインを持つ機能未知の蛋白質 (BAF22640)をコードする遺伝子 (Os07g0693000)の転写開始点が存在すること、が明らかになった。また mPing揷入 位置の上流 752bpには、ュビキチン活性化酵素 E1(BAF22639)をコードする遺伝子が 存在することも明らかになった。 When the above nucleotide sequence was searched for in the chromosomal salt ti 歹1 Jatahose (http://www.shigen.nig.ac.jp/rice/oryzabase/top/top.jsp), mPing was It is inserted near the long end (29430773bp) of chromosome 7 (AP008213, total length 29644043bp), and immediately after 170bp is a gene (Os07g0693000) encoding a protein with unknown protein kinase domain (BAF22640). It became clear that there was a transcription start point. A gene encoding ubiquitin activating enzyme E1 (BAF22639) is located 752 bp upstream of the mPing insertion position. It also became clear that it exists.
[0088] 以上の結果から、稈長ゃ穂長の変異は、前記位置に mPingが揷入され、その下流 にある機能未知の遺伝子の転写量が変化することによって生じた、と推察される。一 方で、上流のュビキチン活性化酵素 E1遺伝子については、 mRNAの転写終了位置よ りも下流に mPingが揷入されていることから、稈長ゃ穂長に関する変異との関係性は 低いと考えられる。 [0088] From the above results, it is inferred that the variation of culm length and panicle length was caused by insertion of mPing at the above position and change in the transcription amount of a gene of unknown function downstream thereof. On the other hand, for the upstream ubiquitin activating enzyme E1 gene, mPing is inserted downstream from the transcription end position of mRNA, so it is considered that the relationship between the cocoon length and the mutation related to panicle length is low. .
[0089] このように、この発明の DNA増幅方法を利用するトランスポゾンディスプレイ法によ つて、突然変異形質と mPing揷入突然変異遺伝子とを関連づけ、機能未知の遺伝子 (Os07g0693000)が稈長ゃ穂長を支配する遺伝子であることが、従来法と比べて著し く短期間'低労力で明らかになった。 [0089] Thus, by the transposon display method using the DNA amplification method of the present invention, the mutant trait and the mPing insertion mutant gene are linked, and the gene of unknown function (Os07g0693000) is used to change the head length. It was revealed that it was a dominant gene in a short period of time and low effort compared to the conventional method.
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006-208422 | 2006-07-31 | ||
| JP2006208422A JP2009278865A (en) | 2006-07-31 | 2006-07-31 | Method for amplification of dna fragment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2008015975A1 true WO2008015975A1 (en) | 2008-02-07 |
Family
ID=38997155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2007/064774 Ceased WO2008015975A1 (en) | 2006-07-31 | 2007-07-27 | Method for amplification of dna fragment |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2009278865A (en) |
| WO (1) | WO2008015975A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010039991A3 (en) * | 2008-10-02 | 2011-03-03 | The Texas A&M University System | Method of generating informative dna templates for high-throughput sequencing applications |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101676108B1 (en) | 2014-11-11 | 2016-11-22 | 충북대학교 산학협력단 | Amplification apparatus and method of Single Strand DNA using Microbeads |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6420117B1 (en) * | 1999-09-14 | 2002-07-16 | The University Of Georgia Research Foundation, Inc. | Miniature inverted repeat transposable elements and methods of use |
| WO2004065556A2 (en) * | 2003-01-17 | 2004-08-05 | E.I. Du Pont De Nemours And Company | Pet family of efflux proteins |
| US20060068394A1 (en) * | 2000-05-20 | 2006-03-30 | Langmore John P | Method of producing a DNA library using positional amplification |
| JP2007049936A (en) * | 2005-08-18 | 2007-03-01 | Wakayama Univ | Mutation detection method, mutation detection program, and storage medium |
-
2006
- 2006-07-31 JP JP2006208422A patent/JP2009278865A/en active Pending
-
2007
- 2007-07-27 WO PCT/JP2007/064774 patent/WO2008015975A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6420117B1 (en) * | 1999-09-14 | 2002-07-16 | The University Of Georgia Research Foundation, Inc. | Miniature inverted repeat transposable elements and methods of use |
| US20060068394A1 (en) * | 2000-05-20 | 2006-03-30 | Langmore John P | Method of producing a DNA library using positional amplification |
| WO2004065556A2 (en) * | 2003-01-17 | 2004-08-05 | E.I. Du Pont De Nemours And Company | Pet family of efflux proteins |
| JP2007049936A (en) * | 2005-08-18 | 2007-03-01 | Wakayama Univ | Mutation detection method, mutation detection program, and storage medium |
Non-Patent Citations (3)
| Title |
|---|
| MARTIN V.J.J. ET AL.: "An alternative inverse PCR (IPCR) method to amplify DNA sequences flanking Tn5 transposon insertions", JOURNAL OF MICROBIOLOGICAL METHODS, vol. 35, no. 2, 1999, pages 163 - 166, XP000946993 * |
| MATSUI K. ET AL.: "Anchor PCR (APCR)-ho o Mochiita Transposon Display ni Okeru Sentaku Enki no Koka", MEM. SCHOOL B.O.S.T. KINKI UNIVERSITY, no. 16, 2005, pages 7 - 12, XP003021003 * |
| OHARA O. ET AL.: "One-sided polymerase chain reaction: The amplification of cDNA", PNAS, vol. 86, no. 15, 1989, pages 5673 - 5677, XP000770757 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010039991A3 (en) * | 2008-10-02 | 2011-03-03 | The Texas A&M University System | Method of generating informative dna templates for high-throughput sequencing applications |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009278865A (en) | 2009-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10858651B2 (en) | Compositions and methods for enrichment of nucleic acids | |
| JP4623910B2 (en) | Methods and kits for identifying elite event GAT-ZM1 in biological samples | |
| CN105121664B (en) | Mixture and its it is compositions related in nucleic acid sequencing approach | |
| EP1546345B1 (en) | Genome partitioning | |
| CN103013966B (en) | SNP markers related to cucumber bitterness traits and their application | |
| TW201321518A (en) | Method of micro-scale nucleic acid library construction and application thereof | |
| WO2018113799A1 (en) | Method and test kit for constructing simplified genomic library | |
| WO2022199242A1 (en) | Set of barcode linkers and medium-flux multi-single-cell representative dna methylation library construction and sequencing method | |
| KR101913735B1 (en) | Internal control substance searching for intersample crosscontamination of nextgeneration sequencing samples | |
| Ahmad et al. | Tracking footprints of CRISPR-based genome editing | |
| WO2008015975A1 (en) | Method for amplification of dna fragment | |
| CN108642199B (en) | SNP (Single nucleotide polymorphism) marker related to growth of millet flag leaves as well as detection primer and application thereof | |
| Peng et al. | Kamchatka crab duplex-specific nuclease-mediated transcriptome subtraction method for identifying long cDNAs of differentially expressed genes | |
| CN108642209B (en) | Wheat plant thousand grain weight judgment marker and application thereof | |
| KR20070033780A (en) | Dwarf transfer factor as a means to develop varieties and useful markers of Chinese cabbage crops, DNA marker factor action primers using them, and varieties of cabbage crops using them | |
| WO2024054768A2 (en) | Brassica cytoplasmic male sterility (cms) fertility restorer nucleic acids, markers, methods, and zygosity assays | |
| CN117363753A (en) | SNP molecular marker related to growth traits and related method and application thereof | |
| CN111763668B (en) | Sequencing primer group and PCR-based whole genome sequencing method | |
| KR102538189B1 (en) | A primer set for detecting active transposon PTE-3 in Chinese cabbage transformants | |
| US11788137B2 (en) | Diagnostic and/or sequencing method and kit | |
| WO2020199127A1 (en) | Design of sequencing primers and pcr-based method for sequencing whole genome | |
| WO2002092847A2 (en) | Method for analysing dna of sweetpotato | |
| JP2011030567A (en) | Dna identification method of paddy rice cultivar hikari shin-seiki of short culm koshihikari type | |
| JP2007049936A (en) | Mutation detection method, mutation detection program, and storage medium | |
| Lynagh et al. | Plant micro-sampling improves germline edit prediction in mosaic backgrounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07791468 Country of ref document: EP Kind code of ref document: A1 |
|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| NENP | Non-entry into the national phase |
Ref country code: RU |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07791468 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) |